amodiaquine has been researched along with chloroquine in 467 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 187 (40.04) | 18.7374 |
| 1990's | 78 (16.70) | 18.2507 |
| 2000's | 113 (24.20) | 29.6817 |
| 2010's | 69 (14.78) | 24.3611 |
| 2020's | 20 (4.28) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
| Buckley, DB; Funk, RS; Hensley, T; Kazmi, F; Loewen, GJ; Parkinson, A; Pope, C | 1 |
| Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
| Chibale, K; Egan, TJ; Jurva, U; Masimirembwa, CM; Njoroge, M; Ongarora, DS; Strydom, N; Wicht, K; Wiesner, L; Wittlin, S | 1 |
| Coelho, L; Lukens, AK; Mazitschek, R; Moreira, R; Nogueira, F; Paulo, A; Santos, SA; Wirth, DF | 1 |
| Behnam, MA; Boldescu, V; Klein, CD; Nitsche, C | 1 |
| Blake, LD; Burrows, JN; Casandra, D; Giarrusso, J; Kyle, DE; LaCrue, AN; Lichorowic, CL; Maignan, JR; Manetsch, R; Mutka, TS; Willis, PA | 1 |
| Combrinck, JM; Egan, TJ; Hunter, R; Smith, PJ; Wicht, KJ | 1 |
| Blake, LD; Burrows, JN; Casandra, D; Kyle, DE; LaCrue, AN; Lichorowic, CL; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Mutka, TS; Neelarapu, R; Willis, PA | 1 |
| Barczyk, A; Buée, L; Carato, P; Coevoet, M; Gay, M; Larchanché, PE; Melnyk, P; Renault, N; Sergeant, N; Yous, S | 1 |
| Bavari, S; Besch, R; Duplantier, AJ; Jay, WB; Kota, KP; Kuehl, K; Lazić, M; Mudhasani, R; Panchal, RG; Pavić, A; Retterer, C; Sean, VA; Selaković, Ž; Šolaja, BA; Soloveva, V; Tran, JP; Vasiljević, B; Verbić, T | 1 |
| Aguiar, ACC; Boechat, N; Carvalho, AS; Coutinho, JP; da Silva, RMRJ; Gandi, MO; Krettli, AU; Mendonça, JS | 1 |
| Attram, HD; Chibale, K; Wittlin, S | 1 |
| Das, US; Khan, SI; Ponnan, P; Rawat, DS; Taylor, D; Tekwani, BL; Tripathi, M; Velpandian, T | 1 |
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Cheong, SL; Ng, CH; Tibon, NS | 1 |
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| de Vera, IMS; Kamenecka, TM; Khan, P; Kojetin, DJ; Lin, H; Munoz-Tello, P | 1 |
| Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
| Heering, J; Kilu, W; Merk, D; Ohrndorf, J; Willems, S | 1 |
| Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y | 1 |
| Merk, D; Willems, S | 1 |
| Cambournac, FJ | 1 |
| Bruce-Chwatt, LJ | 4 |
| Good, MI; Shader, RI | 1 |
| Osifo, NG | 2 |
| Crosby, R; Hamilton, R; Mueller, D; Schmidt, LH; Vaughan, D | 1 |
| Bengtsson, E; Brohult, J; Forslund, J; Hedman, P; Sirleaf, V | 1 |
| Mishra, AK; Sharma, NN | 1 |
| Clyde, DF; Hornick, RB; McCarthy, VC; Miller, RM | 1 |
| Hall, AP; Kosakal, S; Pearlman, EJ; Phintuyothin, P; Segal, HE | 1 |
| Basco, LK; Le Bras, J | 2 |
| Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
| de Geus, A; Malle, LN; Mutabingwa, TK; Wernsdorfer, WH | 1 |
| Brandling-Bennett, AD; Kamsteeg, H; Keuter, M; Khalumi, G; Ngwawe, W; Ronday, M; Sanders, J; Schouten, E; Veltkamp, S; Wetsteyn, JC | 1 |
| Fadat, G; Gardon, J; Gazin, P; Hengy, C; Jambou, R; Louis, FJ; Louis, JP; Trebucq, A | 1 |
| Breman, JG; Koplan, JP; McFarland, D; Sudre, P | 1 |
| Salako, LA; Sowunmi, A | 1 |
| Fadat, G; Gimou, MM; Hengy, C; Le Bras, J; Louis, JP; Verdier, F | 1 |
| Basco, LK | 2 |
| Adoyo, A; Boriga, DA; Kariuki, D; Koech, DK; Magiri, C; Oloo, AJ; Were, JB | 1 |
| Irare, SG; Lemnge, MM; Mhina, JI | 1 |
| Trigg, PI | 1 |
| Carme, B | 1 |
| Carme, B; Mbitsi, A; Moudzeo, H; Ndounga, M; Samba, G | 1 |
| Baird, JK; Bangs, MJ; Basri, H; Jones, TR; Ritonga, A | 1 |
| Broderson, JR; Collins, WE; Ma, NS; Richardson, BB; Skinner, JC; Stanfill, PS | 1 |
| Clarke, JB; Kitteringham, NR; Neftel, K; Park, BK | 1 |
| Bourdeau, EF; Childs, GE; Milhous, WK; Pang, L; Wimonwattratee, T | 1 |
| Carme, B; Chandenier, J; Gay, F; Mbitsi, A; Ndounga, M; Samba, G; Sathounkasi, C; Schmitt, JL | 1 |
| Chakrabarti, NK; Nagaraj, C; Narasimham, MV | 1 |
| Sanghi, SK; Verma, A; Verma, KK | 1 |
| Arrive, A; Eberlé, F; Gazin, P; Hengy, C; Jambou, R; Kouka-Bemba, D | 1 |
| Brandicourt, O; Carme, B; Gay, F; Gentilini, M; Le Bras, J; Mbitsi, A; Moudzeo, H; Ndounga, M; Sathounkazi, C | 1 |
| Dinis, DV; Schapira, A | 1 |
| Breckenridge, AM; Coleman, JW; Maggs, JL; Park, BK; Winstanley, PA | 1 |
| Fasunon, OD; Uwaifo, AO | 1 |
| Boudreau, EF; Childs, GE; Davidson, DE; Milhous, WK; Pang, L; Pooyindee, N; Wimonwattratee, T | 1 |
| Arias, AE; Corredor, A | 1 |
| Abissègue, B; Garrigue, G; Gazin, P; Gelas, H; Ghogomu, NA; Hengy, C; Jambou, R; Kouka-Bemba, D; Le Bras, J | 1 |
| Bellony, S; Claustre, J; Gay, F; Lepelletier, L; Mouchet, J; Nadire-Galliot, M; Poman, JP; Traore, BM | 1 |
| Ndumbe, PM | 1 |
| Pyakalyia, T | 1 |
| Aderounmu, AF; Salako, LA; Simooya, OO | 1 |
| Attanath, P; Benjasurat, Y; Karbwang, J; Looareesuwan, S; Phillips, RE; Warrell, DA; White, NJ | 1 |
| Bada, JL; Gascón, J; Merlos, A; Soldevila, M | 2 |
| Bonnevie, O; Cordoliani, G; Dedet, JP; Germanetto, P; Le Bras, J | 1 |
| Cai, XZ; Fu, SG; Huang, JK; Huang, OL; Ouyang, WC; Pang, XJ; Wang, XF; Wu, Z; Zhang, KY; Zhou, JX | 1 |
| Brubaker, G; Draper, CC; Hills, M; Kilimali, VA | 1 |
| Inambao, AW; Lemnge, MM | 1 |
| Druilhe, P; Gentilini, M; Stahel, E | 1 |
| Cai, XZ; Fu, SG; Huang, JK; Huang, QL; Huang, XF; Pan, XJ; Quyang, WC; Wu, Z; Zhang, KY; Zhou, JX | 1 |
| Campbell, CC; Heymann, DL; Macheso, AP; McDermott, JM; Steketee, RW; Wahl, RD; Wirima, JJ | 1 |
| Rolfe, M | 1 |
| Osanai, CH; Passos, AD; Reyes, S | 1 |
| Ball, J; Franklin, IM; Rhodes, EG | 1 |
| Chanthavanich, P; Karbwang, J; Looareesuwan, S; Phillips, RE; Supanaranond, W; Turner, RC; Warrell, DA; White, NJ | 1 |
| Cutler, DJ; MacIntyre, AC; Tett, SE | 1 |
| Babin-Chevaye, C; Labro, MT | 1 |
| Childs, GE; Pooyindee, N; Wimonwattrawatee, T | 1 |
| Boudreau, EF; Chen, C; Childs, GE; Häusler, B; Milhous, W; Pooyindee, N; Wimonwattrawatee, T | 1 |
| Bugilimfura, L; Deloron, P; Sexton, JD; Sezibera, C | 1 |
| Schapira, A; Schwalbach, JF | 1 |
| Björkman, A; Willcox, M | 1 |
| Buck, RL; Long, GW; Ranoa, CP; Sangalang, RP; Sy, N; Watt, G | 1 |
| Chiodini, PL | 1 |
| Aderounmu, AF; Ekweozor, C; Sodeinde, O | 1 |
| Drouville, C; Guigon, D; Le Bras, J; Porte, J; Simon, F; Verdier, F | 1 |
| Carme, B; Eozenou, P; Mbitsi, A; Moudzeo, H; Ndinga, M | 1 |
| Delmont, J; Faugère, B; Georges, AJ; Limbassa, J; Monges, P; Testa, J | 1 |
| Charmot, G; Le Bras, J; Simon, F | 1 |
| Biaud, JM; Calmel, MB; Clausse, JL; Deloron, P; Hatin, I; Le Bras, J; Marchais, H; Porte, J; Ramanamirija, JA; Simon, F | 1 |
| Brandicourt, O; Brasseur, P; Brucker, G; Danis, M; Datry, A; Druilhe, P; Duflo, B; Gentilini, M; Rosenheim, M | 1 |
| Buisson, Y; Chabiersky, M; Daly, JP; Le Bras, J; Roué, R; Saliou, P; Simon, F; Talarmin, F | 1 |
| Fox, E; Khaliq, AA; Sarwar, M; Strickland, GT | 1 |
| Huang, QL; Wu, Z; Zhang, KY; Zhou, JX | 1 |
| Campbell, CC; Heymann, DL; Khoromana, CO; Wirima, JJ | 1 |
| Coulanges, P; Le Bras, J; Marchais, H; Ramanamirija, JA | 1 |
| Biaud, JM; Coulanges, P; Deloron, P; Le Bras, J; Marchais, H; Ramanamirija, JA | 1 |
| Dixon, PA; Makanjuola, RO; Oforah, E | 1 |
| Breckenridge, A; Edwards, G; Orme, M | 1 |
| Fox, E; Khaliq, AA; Macdonald, M; Sarwar, M; Strickland, GT | 1 |
| Beylot, J; Combe, A; Le Bras, J; Le Bras, M; Raccurt, CP; Ripert, C | 1 |
| Bonanni, LC; Geary, TG; Ginsburg, H; Jensen, JB | 1 |
| Biaud, JM; Coulanges, P; Le Bras, J; Ramanamirija, JA; Ramiliarisoa, O; Verdier, F | 1 |
| Alban, P; Laughlin, LW; Long, GW; Padre, L; Ranoa, CP; Sangalang, R; Watt, G | 1 |
| Gyr, N; Schär, M; Stürchler, D | 1 |
| Dedet, JP; Esterre, P | 1 |
| Breckenridge, A; Edwards, G; Orme, M; Winstanley, P | 1 |
| Alpers, MP; Heywood, PF; Jolley, DJ; Moir, JS; Tulloch, JL; Vrbova, H | 2 |
| Alcantara, AK; Buck, RL; Rodriguez, CS; Smrkovski, LL; Uylangco, CV | 1 |
| Arias, AE; Cortes, GT; Espinal, CA; Guerra, P | 1 |
| Nguyen-Dinh, P | 1 |
| Coulanges, P; Deloron, P; Le Bras, J; Ramanamirija, JA | 2 |
| Biaud, JM; Coulanges, P; Deloron, P; Le Bras, J; Ramanamirija, JA | 1 |
| Spencer, HC | 1 |
| Salako, LA | 1 |
| Blayo, MC; Pussard, E; Verdier, F | 1 |
| Chaves-Carballo, E; Collins, WE; Glew, RH; Howard, WA; Miller, LH; Neva, FA; Wyler, DJ | 1 |
| Fitch, CD | 1 |
| Peters, W | 3 |
| Chevli, R; Fitch, CD; Gonzalez, Y | 1 |
| Clyde, DF; DuPont, HL; Hornick, RB; McCarthy, VC | 1 |
| Jindal, MN; Kelkar, VV; Pandya, KH | 1 |
| Dola, SK | 1 |
| Adeleye, I; Cooke, A; Fasan, PO; Kofie, BA | 1 |
| Alvarez Sotolongo, M; Krácmar, J; Krácmarová, J | 1 |
| Johnson, CM; Young, MD | 1 |
| Ray, AP; Sangalang, R; Shute, GT | 1 |
| Johnson, CM; Molina, JJ; Young, MD | 1 |
| Geiman, QM; Schnell, JV; Siddiqui, WA | 1 |
| Clyde, DF | 1 |
| Powell, RD | 1 |
| Clyde, DF; Gilman, RH; McCarthy, VC; Miller, RM | 1 |
| Harvey, RP; Imperato, PJ; Shookhoff, HB | 1 |
| Saint-Yves, IF | 1 |
| Weise, HJ | 1 |
| Benazet, F; Godard, C | 1 |
| Elslager, EF | 1 |
| Denoël, A | 1 |
| Hunsicker, LG | 1 |
| Clyde, DF; DuPont, HL; McCarthy, VC; Miller, RM | 1 |
| Rieckmann, KH | 1 |
| Myint, UH; Win, UK | 1 |
| Lantz, CH; Van Dyke, K | 1 |
| Harrison, SL | 1 |
| Cantrell, W; Elko, EE | 1 |
| Jindal, MN | 1 |
| Ghiassedin, M; Mofidi, C; Motabar, M; Rouhani, F; Saebi, A | 1 |
| Knüttgen, HJ | 1 |
| Schneider, MD | 1 |
| Bayles, A; Olszewski, B; Thompson, PE; Waitz, JA | 1 |
| Nurse, GT | 1 |
| Boriga, DA; Kariuki, DM; Kipingor, T; Koech, DK; Sixsmith, DG; Spencer, HC; Watkins, WM | 1 |
| Churchill, FC; Koech, DK; Oloo, AJ; Sixsmith, DG; Spencer, HC; Watkins, WW | 1 |
| Deloron, P; Le Bras, J; Ramanamirija, JA | 1 |
| Stürchler, D | 1 |
| Beale, GH; Chutmongkonkul, M; Thaithong, S | 1 |
| Agure, R; Chulay, JD; Kipingor, T; Koech, DK; Spencer, HC | 1 |
| Campbell, CC; Khatib, OJ; Payne, D; Schwartz, IK | 1 |
| Mackenzie, AH | 1 |
| Nieuwoudt, NJ | 1 |
| Rosário, VE; Vasconcelos, MA | 1 |
| Bademosi, K; Obih, PO; Salako, LA; Sodeinde, O; Walker, O | 1 |
| Coulanges, P; Deloron, P; Le Bras, J; Ramanamirija, JA; Verdier, P | 1 |
| Coulanges, P; Deloron, P; Ramanamirija, JA; Verdíer, F | 1 |
| Phillips, RE | 1 |
| Loban, KM; Polozok, ES | 1 |
| Gould, S; Warhurst, DC | 1 |
| Elgart, M; Isaacson, D; Turner, ML | 1 |
| Ma, K; Sourkes, TL | 1 |
| D'Amico, DJ; Kenyon, KR | 1 |
| Eamsobhana, P; Sucharit, P | 1 |
| Tulloch, A | 1 |
| Harvey, P; Sharp, PT | 1 |
| Barkakaty, BN; Das, S; Deka, RP; Pattanayak, S; Roy, RG; Sen, T | 1 |
| Coosemans, M; Wery, M | 1 |
| Darlow, B; Stace, J; Vrbova, H | 1 |
| Sweeney, TR | 1 |
| Obih, PO; Olatunde, A | 1 |
| Alvar, J; Amela, C; Benito, A; Molina, R; Roche, J | 1 |
| Bekobita, D; Munafu, CG; Nevill, CG; Ochen, K; Sezi, CL | 1 |
| Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 1 |
| Assi-Coulibaly, L; Ehouman, A; Kaptué, B; Konan, D; Penali, LK | 1 |
| Burnham, G; Kamugisha, J; Kipp, W | 1 |
| Yang, H; Yang, P; Yang, Y | 1 |
| Munafu, CG; Nevill, CG; ten Hove, WR; van der Kaay, HJ; Verhoeff, FH; Were, JB | 1 |
| Barkakaty, BN; Narasimham, MV; Pandya, AP | 1 |
| Hovette, P; Martet, G; Merouze, F; Nicolas, P; Touze, JE | 1 |
| Cowman, AF; Deady, LW; Foley, M; Ng, K; Tilley, L | 1 |
| Boeyé, A; Kronenberger, P; Vrijsen, R | 1 |
| Carnevale, P; Cot, M; Dechering, K; Meuwissen, JH; Mulder, B; Robert, V; Stoffels, H; Tchuinkam, T; Verhave, JP | 1 |
| Harrison, AC; Hawley, SR; O'Neill, PM; Park, BK; Storr, RC; Ward, SA | 1 |
| Hagos, B; Kariuki, D; Khan, B; Martin, SK; Ofulla, AV | 1 |
| Afari, EA; Akanmori, BD; Nakano, T; Ofori-Adjei, D | 1 |
| Fowler, VG; Irare, SG; Lemnge, M; Malecela, E; Mashaka, M; Mhina, J; Mtoi, R; Mtui, S | 1 |
| Alvar, J; Amela, C; Ayecaba, S; Benito, A; Molina, R; Roche, J | 1 |
| Baba, H; Campistron, G; Chretien, P; Coulais, Y; Laurent, F; Magnaval, JF; Peyron, F; Saivin, S; Sqalli, A; Tufenkji, AE | 1 |
| Afshar, A; Edrissian, GH; Mohsseni, G; Satvat, MT; Sayedzadeh, A | 1 |
| Lal, S; Misra, SP; Nandi, J | 1 |
| Agnamey, PP; Brasseur, P; Kouamouo, J; Leroy, G | 1 |
| Drakeley, C; Greenwood, B; Jaffar, S; Joof, D; Müller, O; Okorie, C; Pinder, M; van Hensbroek, MB | 1 |
| Anabwani, GM; Esamai, FO; Menya, DA | 1 |
| Bray, PG; Hawley, SR; Park, BK; Ward, SA | 1 |
| Bray, PG; Hawley, SR; Naisbitt, DJ; O'Neill, PM; Park, BK; Ward, SA | 1 |
| Brasseur, P; Garner, P; LeBras, J; Mussano, P; Nevill, C; Olliaro, P; Ringwald, P | 1 |
| Bloland, PB; Ruebush, TK | 1 |
| Krishna, S; White, NJ | 1 |
| Bailey, R; Drakeley, CJ; Duraisingh, MT; Greenwood, BM; Muller, O; Snounou, G; Targett, GA; Warhurst, DC | 1 |
| Akkawi, M; Blauer, G | 1 |
| Barlin, GB; Edstein, MD; Kotecka, BM; Rieckmann, KH | 1 |
| Croft, SL; Elueze, EI; Warhurst, DC | 1 |
| Boudin, C; Chambon, R; Cot, M; de Vries, C; Foumane, V; le Hesran, JY; Personne, P; Verhave, JP | 1 |
| Balasubramanian, KA; Madesh, M | 1 |
| Adagu, IS; Machado, RL; Miles, MA; Oliveira, SG; Póvoa, MM; Warhurst, DC | 1 |
| al-Yaman, F; Alpers, MP; Genton, B; Mokela, D; Narara, A; Raiko, A | 1 |
| Dong, Y; Huang, KG; Liao, MZ; Liu, DQ; Yang, HL; Yang, PF; Yang, YM; Zhang, CY | 1 |
| Boudin, C; Chambon, R; Chandenier, J; Lemardeley, P; Ringwald, P | 1 |
| Greenwood, BM; McIntosh, HM | 1 |
| Doury, JC; Fusai, T; Hienne, R; Parzy, D; Pradines, B; Spiegel, A; Tall, A; Trape, JF | 1 |
| Bray, PG; Mungthin, M; Ridley, RG; Ward, SA | 1 |
| Famin, O; Ginsburg, H; Krugliak, M; Zhang, J | 1 |
| Chatterjee, T; Giri, AK; Khan, KA; Muhkopadhyay, A | 1 |
| Doury, JC; Kombila, M; Lebeau, C; Mabika Mamfoumbi, M; Mourou Mbina, JR; Owono Medang, M; Parzy, D; Pradines, B | 2 |
| Famin, O; Ginsburg, H; Krugliak, M | 1 |
| Angkasekwinai, P; Buranakiti, A; Chaiyaroj, SC; Cowman, AF; Looressuwan, S | 1 |
| Makonnen, E; Mengesha, T | 1 |
| Fusai, T; Mosnier, J; Parzy, D; Pradines, B; Rogier, C; Spiegel, A; Tall, A; Trape, JF | 1 |
| McIntosh, HM | 2 |
| Bachhawat, K; Surolia, A; Surolia, N; Thomas, CJ | 1 |
| Collins, WE; Fryauff, DJ; Galland, GG; Jennings, V; Kendall, J; Morris, CL; Sullivan, JS | 1 |
| Blair, S; Fonseca, JC; Lacharme, LL; Tobón, A | 1 |
| Robert, V; Sokhna, CS; Trape, JF | 1 |
| Adedeji, AA; Ayede, AI; Falade, AG; Falade, CO; Happi, TC; Ndikum, VN; Oduola, AM; Sowunmi, A; Sowunmi, CO | 1 |
| Bouyou Akotet, M; Guiyedi, V; Koko, J; Kombila, M; Mabika Manfoumbi, M; Matsiégui, PB; Traoré, B | 1 |
| Mengesha, T; Seboxa, T | 1 |
| Björkman, A; Gupta, S; Mariga, ST; Thapar, MM; Wernsdorfer, WH | 1 |
| Moyen, G; Samba, G; Talani, P | 1 |
| Blair-Trujillo, S; Carmona-Fonseca, J; Lacharme-Lora, L | 1 |
| Sowunmi, A | 2 |
| Basco, LK; Keundjian, A; Ndounga, M; Ringwald, P | 1 |
| Agnamey, P; Brasseur, P; Galega, PF; Moyou, SR | 1 |
| Basco, LK; Ringwald, P | 1 |
| Fidock, DA; Sidhu, AB; Verdier-Pinard, D | 1 |
| Adedeji, AA; Sowunmi, A | 1 |
| Cravo, P; do Rosário, VE; Gil, JP; Lopes, D; Nogueira, F; Rungsihirunrat, K; Seugorn, A | 1 |
| Ericsson, O; Gustafsson, LL; Minzi, OM; Rais, M; Svensson, JO | 1 |
| Gao, B; Huang, K; Yang, H | 1 |
| Huang, K; Liao, M; Liu, D; Yang, H; Yang, P; Yang, Y; Zhang, C | 1 |
| Dorsey, G; Gasasira, AF; Kamya, MR; Nassali, A; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Ariey, F; Duchemin, JB; Harisoa, JL; Mauclere, P; Pietra, V; Rabarijaona, LP; Raharimalala, LA; Rakotomanana, F; Ranaivo, L; Randrianarivelojosia, M; Robert, V | 1 |
| Mussano, P; Olliaro, P | 1 |
| Makama, S; Shabahang, J; Tavrow, P | 1 |
| Fateye, BA; Sowunmi, A | 1 |
| BASU, PC; RAY, AP | 1 |
| CAMBOURNAC, FJ; DA FONSECA, AE; QUEIROS, JS | 1 |
| MILLER, MJ | 1 |
| PETER, G | 1 |
| LAMADRID-MONTEMAYOR, F | 1 |
| HOUEL, G; VAN GOOR, WT | 1 |
| SRIVASTAVA, JR | 1 |
| HOEKENGA, MT | 2 |
| WALKER, AJ | 1 |
| BORODA, C | 1 |
| AGARWAL, SL; ARORA, RB | 1 |
| GRUPPER, C | 1 |
| CHARLES, LJ | 1 |
| CAHN, MM; LEVY, EJ; SHAFFER, B | 1 |
| Keus, K; Nzila, A; Ochong, EO; van den Broek, IV | 1 |
| GROUNDS, JG | 1 |
| MUNTENDAM-EVENHUIS, JD | 1 |
| YOUNG, MD | 2 |
| NOVA, F | 1 |
| RYCKEWAERT, A | 1 |
| SASLAW, S; SCHAEFER, J | 1 |
| AMMA, MK; GUJRAL, ML; MISRA, N; SAREEN, K; VARMA, DR; VIJAYAMMA, N | 1 |
| KLINGMUELLER, G | 1 |
| CONTACOS, PG; MILLAR, JW; STITCHER, JE; YOUNG, MD | 1 |
| COLLINS, WE; JEFFERY, GM; SKINNER, JC | 2 |
| ARORA, RB; LAL, A | 1 |
| ALLING, DW; CANTRELL, WF; JACOBS, RL | 1 |
| SCHULEMANN, W; TAUBERGER, G | 1 |
| SULLI, G; VARRONE, F | 1 |
| DESHPANDE, VR; TIWASKAR, HV | 1 |
| EL-MOFTY, AM | 1 |
| ALVING, AS; BREWER, GJ; MILLAR, JW; POWELL, RD | 1 |
| ZUIDEMA, PJ | 1 |
| ALVING, AS; BREWER, GJ; DEGOWIN, RL; POWELL, RD | 1 |
| AUDU, IS; COLLIS, WR | 1 |
| DAVID, HL | 1 |
| BHATTACHARJEE, SK; DUTTA, CP; PRADHAN, J | 1 |
| KERSLEY, GD; PALIN, AG | 1 |
| Warhurst, DC | 1 |
| Adeniji, B; Afolabi, BM; Amajoh, CN; Ekanem, OJ; Molta, NB; Odujoko, JB; Oguche, S; Omalu, IC; Pam, SD; Wuyep, VP | 1 |
| Adonis-Koffy, L; Daubrey, T; Kabran, J; Kouadio, A; Timité-Konan, AM | 1 |
| HOEKENGA, MT; MAXIMO, QG | 1 |
| REINERTSON, JW; THOMPSON, PE | 1 |
| Ginsburg, H; Golenser, J | 1 |
| Casey, GJ; Cowman, AF; Genton, B; Ginny, M; Mueller, I; Reeder, JC; Uranoli, M | 1 |
| Abacassamo, F; Alonso, PL; Aponte, JJ; Barreto, A; Enosse, S; Gómez-Olivé, FX; Mabunda, S; Magnussen, P; Quintó, L; Rønn, AM; Thompson, R | 1 |
| Bakyaita, N; D'Alessandro, U; Egwang, TG; Langi, P; Mutabingwa, TK; Nalunkuma-Kazibwe, A; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| Ardizzoni, E; Bakyaita, N; Balkan, S; Brockman, A; Checchi, F; Guthmann, JP; Klarkowski, D; Kosack, C; Kwezi, E; Piola, P; Priotto, G | 1 |
| Majori, G | 1 |
| Cassano, F; Cavailler, P; Guthmann, JP; Kariuki, D; Mwangi, J; Omar, SA; Piola, P; Stivanello, E | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Happi, TC; Sowunmi, A | 1 |
| Adedeji, AA; Babalola, CP; Fateye, BA; Sowunmi, A | 1 |
| Gerstner, U; Prajakwong, S; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, G | 1 |
| Casabianca, LB; de Dios, AC; Kosar, A; Roepe, PD | 1 |
| Dokomajilar, C; Dorsey, G; Kamya, MR; Kiggundu, M; Rosenthal, PJ; Staedke, SG | 1 |
| Baerwaldt, T; Checchi, F; Danks, A; Durand, R; Heinzelmann, A; Hora, B; Kamara, S; Lamotte, Nd; Morineau, G; Oloo, A; Pinoges, L; Ranford-Cartwright, L; Roddy, P; Smet, M; Williams, A; Wurie, AR | 1 |
| Amankwa, J; Ansah, NA; Ansah, P; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Mumuni, G; Oduro, AR | 1 |
| Göbels, K; Graupner, J; Grobusch, MP; Häussinger, D; Lund, A; Richter, J | 1 |
| Atkin, S; Checchi, F; Ford, N; Hamour, S; Hook, C; Keus, K; Melaku, Y; Montgomery, J; Wambugu, J | 1 |
| Ampuero, J; Balkan, S; D'Alessandro, U; Denoncin, A; Dujardin, JC; Dunand, J; Fortes, F; Franco, J; Gaboulaud, V; Gillet, P; Guthmann, JP; Legros, D; Saraiva, N; Tobback, S; van Herp, M; van Overmeir, C | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, S; Reingold, A; Rosenthal, PJ; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Djalle, D; Koula, MR; Madji, N; Manirakiza, A; Menard, D; Talarmin, A | 1 |
| Ahmad, F; Durrani, N; Graham, K; Leslie, T; Rahim, S; Rowland, M | 1 |
| Aguttu, C; Kaddumukasa, M; Kironde, F; Nassejje, M; Ndagire, D; Pettersson, M; Sendagire, H; Swedberg, G | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, SL; Reingold, A; Rosenthal, PJ; Slater, M; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Abuaku, B; Duah, N; Koram, KA; Quashie, N | 1 |
| Agnamey, P; Brasseur, P; Cisse, M; Dumoulin, J; Gaye, O; Olliaro, P; Rigal, J; Taylor, WR | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Jones, KL; McIntosh, HM | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Adjetey, TA; Affoumou, GB; Barro-Kiki, P; Kone, M; Loukou, DD; Menan, EI; Nebavi, NG; Yavo, W | 1 |
| Bachy, C; D'Alessandro, U; Donam, I; Grandesso, F; Guthmann, JP; Habimana, J; Kerah, CH; Maikere, J; Ntambi, J; Vanlerberghe, V | 1 |
| Akanmori, BD; Goka, BQ; Kurtzhals, JA; Ofori-Adjei, D; Quashie, NB | 1 |
| D'Alessandro, U; Erhart, A; Karema, C; Mupfasoni, D; Rusanganwa, E; Rwagacondo, C; Tinto, H; Van Marck, E; Van Overmeir, C; Vandoren, W | 1 |
| Dokomajilar, C; Dorsey, G; Francis, D; Kamya, MR; Machekano, R; Nsobya, SL; Rosenthal, PJ; Talisuna, A; Yeka, A | 1 |
| Carmona-Fonseca, J; Guzmán, V | 1 |
| Abdulla, S; Bloland, P; Mandike, R; Mills, A; Mulligan, JA; Palmer, N; Williams, H | 1 |
| Agnamey, P; Brasseur, P; de Pecoulas, PE; Olliaro, P; Vaillant, M | 1 |
| Alifrangis, M; Bygbjerg, IC; Dalgaard, MB; Enevold, A; Jensen, AT; Khalil, IF; Lemnge, MM; Lusingu, JP; Rønn, AM; Staalsoe, T; Theander, TG; Vestergaard, LS; Warhurst, DC | 1 |
| Asadollaly, E; Berry, NG; Biagini, GA; Bray, PG; Jeyadevan, JP; O'Neill, PM; Park, BK; Ward, SA | 1 |
| Bitarakwate, E; Dorsey, G; Hwang, J; Pai, M; Reingold, A; Rosenthal, PJ | 1 |
| Lalou, R; Le Hesran, JY; Sene, I; Souares, A; Sow, D | 1 |
| Aaby, P; Bergquist, Y; Kofoed, PE; Poulsen, A; Rodrigues, A; Rombo, L; Ursing, J | 1 |
| Balkan, S; Checchi, F; Cousens, S; Guthmann, JP; Legros, D; Olliaro, P; Pinoges, L; van Herp, M | 1 |
| Abodo, RT; Basco, LK; Ndounga, M; Ngane, VF; Same-Ekobo, A; Soula, G; Youmba, JC | 1 |
| Houzé, S; Kaddouri, H; Le Bras, J; Mentré, F; Nakache, S | 1 |
| Browne, E; Bruce, J; Chandramohan, D; Greenwood, B; Randal, A; Tagbor, H | 1 |
| Bell, DJ; Molyneux, ME; Nyirongo, SK; Ward, SA; Winstanley, PA | 1 |
| Aguttu, C; Anokbonggo, WW; Chiria, J; Gustafsson, LL; Hellgren, U; Obua, C; Ogwal-Okeng, JW | 1 |
| Adedeji, AA; Fateye, BA; Gbotosho, GO; Happi, TC; Sowunmi, A | 1 |
| Kobbe, R; May, J; Meyer, CG | 1 |
| Deharo, E; Garavito, G; Maurel, S; Monje, MC; Nepveu, F; Valentin, A | 1 |
| Adagu, IS; Fivelman, QL; Warhurst, DC | 1 |
| Gil, JP; Kofoed, PE; Rodrigues, A; Rombo, L; Ursing, J | 1 |
| Andrianina, NN; Jahevitra, M; Ménard, D; Ramiandrasoa, Z; Randriamanantena, A; Rasoarilalao, N; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Abuaku, B; Duah, NO; Koram, KA; Quashie, NB | 1 |
| Hu, C; Lee, H; Solomon, VR; Ulibarri, G; Zhang, H | 1 |
| Andrianantenaina, HB; Ariey, F; Domarle, O; Randrianarivelojosia, M; Rason, MA; Raveloson, A | 1 |
| Adjei, L; Anemana, SD; Bienzle, U; Burchard, GD; Eggelte, TA; Ehrhardt, S; Kaiser, S; Mockenhaupt, FP | 1 |
| Ariey, F; Bedja, SA; Rabarijaona, LP; Randrianarivelojosia, M; Robert, V; Tall, A | 1 |
| Adedeji, AA; Bolaji, OM; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, CT; Oduola, AM; Sowunmi, A | 1 |
| Blair, S; Carmona, J; Maestre, A; Montoya, P; Tobón, A | 1 |
| Atissou, JF; Evi, JB; Kassi, RR; Kiki-Barro, PC; Kone, M; Menan, EI; Oga, SS; Yavo, W | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Beck, HP; Genton, B; Goroti, M; Maku, P; Marfurt, J; Müeller, I; Reeder, JC; Sie, A | 1 |
| Akida, JA; Lemnge, MM; Lugimbana, L; Malebo, HM; Malle, LN; Segeja, MD | 1 |
| Stepniewska, K; White, NJ | 1 |
| D'Alessandro, U; Guekoun, L; Guiguemdé, RT; Ouédraogo, JB; Tinto, H; Zongo, I | 1 |
| Egan, TJ; Hoppe, HC; Joiner, KA; Roberts, L | 1 |
| Kolawole, SO; Ogungbamigbe, TO; Ogunro, PS; Ojurongbe, O; Okanlawon, BM | 1 |
| Arango, E; Cravo, P; Do Rosário, VE; Maestre, A; Restrepo-Pineda, E | 1 |
| Amalvict, R; Baret, E; Briolant, S; Fontaine, A; Fraisse, L; Fusaï, T; Henry, M; Mosnier, J; Pradines, B; Rogier, C | 1 |
| Cortés, LJ; Guerra, AP; Knudson, A; Nicholls, RS; Pérez, MA; Usta, C | 1 |
| Basque, J; Cantin, AM; Leduc, R; Martel, M | 1 |
| Cui, L; Gao, B; Li, X; Yang, H; Yang, P; Yang, Y; Yang, Z; Zhang, Z | 1 |
| Akida, JA; Bygbjerg, IC; Chile, MM; Kitua, AY; Lemnge, MM; Lusingu, JP; Makunde, R; Malebo, HM; Massaga, JJ; Rønn, AM; Theander, TG | 1 |
| Atta, H; Elmi, HH; Hassan, AM; Hassan, HM; Jibril, AM; Klena, JD; Waqar, BA; Warsame, M | 1 |
| Engl, M; Gluderer, D; Ogwang, M; Ploner, F; Ploner, M; Prugger, C; Wernsdorfer, G; Wernsdorfer, WH | 1 |
| Congpuong, K; Frank, C; Ley, B; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH | 1 |
| Anstey, NM; Chalfien, F; Hasugian, AR; Kenangalem, E; Marfurt, J; Penttinen, PM; Piera, KA; Price, RN; Purba, HL; Ratcliff, A; Russell, B; Siswantoro, H; Tjitra, E; Wuwung, RM | 1 |
| Beavogui, AH; Dama, S; Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Kone, A; Maiga, H; Ouologuem, D; Sagara, I; Tekete, M; Wele, M | 1 |
| Asadollahy, E; Bambal, RB; Bates, M; Berry, N; Biagini, G; Bray, PG; Brigandi, RA; Davies, J; Davis, CB; Gargallo, DV; Gomez-de-Las-Heras, FM; Gresham, SL; Hall, C; Hindley, S; Lander, H; Maggs, JL; Nixon, G; O'Neill, PM; Parapini, S; Park, BK; Rimmer, K; Roberts, P; Shone, AE; Stanford, D; Stocks, PA; Taramelli, D; Vivas, L; Ward, SA; Winstanley, PA | 1 |
| Abiodun, O; Bell, A; Brun, R; Chollet, J; Irungu, BN; Kiboi, DM; Langat, B; Nganga, JK; Nyambati, VC; Nzila, A; Rukunga, GM; Wittlin, S | 1 |
| Fay, MP; Hayton, K; Reyes, S; Ringwald, P; Sá, JM; Twu, O; Wellems, TE | 1 |
| Baisor, M; Beck, HP; Genton, B; Hastings, IM; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Oguonu, T; Okafor, HU; Shu, EN | 1 |
| Boussinesq, M; Djomo, PN; Kamgno, J; Pion, SD; Thylefors, B | 1 |
| Almeras, L; Amalvict, R; Baret, E; Briolant, S; Gil, M; Henry, M; Parquet, V; Pradines, B; Rogier, C; Wurtz, N | 1 |
| Blair, S; Deharo, E; Pabón, A | 1 |
| Alumasa, JN; Casabianca, LB; Comstock, E; de Dios, AC; Gorka, AP; Roepe, PD | 1 |
| Sa, JM; Twu, O | 1 |
| Amalvict, R; Baret, E; Briolant, S; Charras, S; Feraud, M; Henry, M; Huyghues des Etages, E; Pascual, A; Pradines, B; Rogier, C | 1 |
| Auschwitz, JM; Carter, MD; Johnson, JD; Lee, PJ; Leed, SE; Sandlin, RD; Wright, DW | 1 |
| Kurawattimath, V; Mandlekar, S; Mariappan, TT; Pocha, K; Trivedi, RK | 1 |
| Dal-Bianco, M; Dietz, K; Frank, M; Gabor, J; Grobusch, MP; Kombila, DU; Kremsner, PG; Lehners, N; Lell, B; Mayengue, PI; Ngoma, GM; Ntoumi, F; Supan, C | 1 |
| Coluzzi, M; Gramolelli, S; Modiano, D; Paganotti, GM; Romano, R; Russo, G; Tabacchi, F | 1 |
| Anvikar, AR; Bhatt, RM; Dash, AP; Ghosh, SK; Kumar, A; Mohanty, SS; Pillai, CR; Sharma, B; Sharma, SK; Valecha, N | 1 |
| Anstey, NM; Chalfein, F; Haynes, RK; Kenangalem, E; Marfurt, J; Möhrle, JJ; Piera, KA; Prayoga, P; Price, RN; Sebayang, B; Wabiser, F; Wirjanata, G; Wittlin, S | 1 |
| Ali, A; Björkman, A; Ferreira, PE; Fröberg, G; Gil, JP; Mårtensson, A | 1 |
| Ajeigbe, KO; Emikpe, BO; Olaleye, SB | 1 |
| Beeson, JG; Goodman, CD; Langer, C; McFadden, GI; Wilson, DW | 1 |
| Cooksey, R; Dahlström, S; Fairhurst, RM; Flegg, JA; Guerin, PJ; Johnson, JD; Le Bras, J; Le Nagard, H; Lim, P; Ménard, D; Mentré, F; Murillo, C; Musset, L; Noedl, H; Nosten, F; Nsobya, SL; Pradines, B; Quashie, NB; Sibley, CH; Sinou, V; Sriprawat, K; Woodrow, CJ | 1 |
| Arzika, I; Fandeur, T; Guillebaud, J; Issaka, M; Maazou, A; Salissou, A; Specht, S; Zamanka, H | 1 |
| Akala, HM; Andagalu, B; Bulimo, W; Cheruiyot, A; Eyase, FL; Ingasia, L; Johnson, JD; Juma, D; Kamau, E; Okudo, C; Omondi, A; Schnabel, D; Walsh, DS; Wanja, E; Waters, NC; Yeda, R | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| NAIR, CP; RAY, AP | 1 |
| CHAUDHURI, RN; DUTTA, BN; GOSH, S; RAI CHAUDHURI, MN | 1 |
| HAMILTON, CS | 1 |
| Antonia, AL; Emch, M; Janko, M; Meshnick, SR; Taylor, SM; Tshefu, AK | 1 |
| Bala, N; Betuela, I; Davis, TM; Hetzel, MW; Lavu, EK; Page-Sharp, M; Pulford, J | 1 |
| Adam, I; Ademowo, G; Arze, C; Baliraine, FN; Berens-Riha, N; Björkman, A; Borrmann, S; Checchi, F; Dahal, P; Davis, TME; Desai, M; Dhorda, M; Djimdé, AA; Dorsey, G; El-Sayed, BB; Eshetu, T; Eyase, F; Falade, C; Faucher, JF; Fröberg, G; Gadalla, NB; Grivoyannis, A; Guérin, P; Hamour, S; Houzé, S; Johnson, J; Kamugisha, E; Kariuki, S; Kiechel, JR; Kironde, F; Kofoed, PE; LeBras, J; Malmberg, M; Mårtensson, A; Ménard, D; Moriera, C; Mwai, L; Ngasala, B; Nosten, F; Nsanzabana, C; Nsobya, SL; Nzila, A; Oguike, M; Ogutu, B; Otienoburu, SD; Ouédraogo, JB; Piola, P; Plowe, CV; Price, RN; Rombo, L; Rosenthal, PJ; Schramm, B; Sibley, CH; Somé, AF; Stepniewska, K; Sutherland, CJ; Thwing, J; Ursing, J; Venkatesan, M; Wong, RPM; Zeynudin, A; Zongo, I | 1 |
| Arboleda, M; Blair, S; Fernández, D; Garavito, G; Pabón, A; Segura, C | 1 |
| Baret, E; Bercion, R; Camara, C; Diatta, B; Diémé, Y; Fall, B; Fall, KB; Fall, M; Mbaye, PS; Nakoulima, A; Pascual, A; Pradines, B; Wade, B; Wurtz, N | 1 |
| Bouyou Akotet, MK; Guiyedi, V; Kombila, M; Maboko, F; Mawili-Mboumba, DP; Mourou Mbina, JR; Ndong Ngomo, JM | 1 |
| Abiodun, OO; Akinola, O; Falajiki, YF; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Bigira, V; Bloome, J; Byaruhanga, O; Conrad, MD; Cooper, RA; Dorsey, G; Greenhouse, B; Gut, J; Havlir, DV; Kakuru, A; Kamya, MR; Kapisi, J; Kozak, B; LeClair, N; Legac, J; Nakazibwe, C; Nsobya, SL; Okiring, J; Rosenthal, PJ; Tumwebaze, P; Walakira, A | 1 |
| Combrinck, JM; Egan, TJ; Fong, KY; Gibhard, L; Smith, PJ; Wright, DW | 1 |
| Han, BS; Han, M; Jeong, I; Kim, CH; Kim, DJ; Kim, KS; Kim, WG; Lee, EH; Moon, J; Naffin-Olivos, JL; Nguyen, QT; Park, CH; Petsko, GA; Rajan, S; Ringe, D; Shin, J; Sohn, M; Tu, Y; Yoon, HS | 1 |
| Barnwell, JW; Goldman, I; Juma, E; Kariuki, S; Komino, F; Lucchi, NW; Okoth, SA; Onyona, P; Shi, YP; Udhayakumar, V; Wiegand, RE | 1 |
| Auburn, S; Handayuni, I; Marfurt, J; Noviyanti, R; Pava, Z; Poespoprodjo, JR; Price, RN; To, S; Trianty, L; Wirjanata, G | 1 |
| Adepiti, AO; Bolaji, OO; Elujoba, AA | 1 |
| Hwang, ES; Jang, EJ; Jeong, MG; Kim, HK; Kim, KS; Oh, S; Shin, JH; Won, HY | 1 |
| Benoit, N; Boussaroque, A; Diatta, B; Diemé, Y; Dionne, P; Fall, B; Fall, KB; Fall, M; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Craig, JC; Raheem, KS; Warhurst, DC | 1 |
| Grobusch, MP; Hakizimana, E; Kateera, F; Kumar, N; Mens, PF; Mutesa, L; Nsobya, SL; Tukwasibwe, S; van Vugt, M | 1 |
| Arez, AP; Berzosa, P; de Sousa, B; Guerra, M; Mendes, C; Ndong-Mabale, N; Neres, R; Salgueiro, P | 1 |
| Alencar Filho, AC; Alencar, AC; Daniel-Ribeiro, CT; Felger, I; Kuehn, A; Lacerda, MV; Lameyre, V; Machado, K; Magalhaes, BL; Manso, MC; Marques, MM; Melo, GC; Siqueira, AM; Vieira, JL | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Amalvict, R; Bercion, R; Diatta, B; Diawara, S; Fall, B; Gueye, MW; Kounta, MB; Lo, G; Madamet, M; Nakoulima, A; Pradines, B; Wade, KA | 1 |
| Affara, M; Bei, AK; Deme, AB; Dieye, B; Diongue, K; Gaye, A; Koita, O; Krogstad, DJ; Mbaye, A; Ndiaye, D; Ndiaye, IM; Ndiaye, T; Ndiaye, YD; Nwakanma, D; Sy, M; Sy, N; Volkman, S; Yade, MS | 1 |
| Avery, SV; Vallières, C | 1 |
| Nguyen, TQ; Olafson, KN; Rimer, JD; Vekilov, PG | 1 |
| Byaruhanga, O; Ceja, FG; Conrad, MD; Cooper, RA; Katairo, T; Nsobya, SL; Rasmussen, SA; Rosenthal, PJ; Tumwebaze, PK | 1 |
| Affara, M; Ahmad, A; Amambua-Ngwa, A; Ceesay, S; D'Alessandro, U; El-Fatouri, F; Janha, R; Joof, F; Kolly, O; Mbye, H; Nwakanma, D; Nyang, H; Okebe, J | 1 |
| Avery, SV; Islahudin, F; Lakhani, DH; Tindall, SM; Ting, KN; Vallières, C | 1 |
| Heo, JH; Jeong, HY; Jun, HH; Kang, JM; Kim, DJ; Lee, SH; Lee, SY; Park, SH; Sung, MJ; Yang, DH | 1 |
| Baska, KS; Dalal, S; Dhingra, SK; Fidock, DA; Garcia, CRS; Klein, MS; Klemba, M; Krishna, S; Lee, AH; Lewis, IA; Llinás, M; Roepe, PD; Rubiano, K; Singh, MK; Siriwardana, A | 1 |
| Churcher, ZR; Johnson, PE; Slavkovic, S | 1 |
| Cumming, BM; Goldring, JPD | 1 |
| Schmidt, JG; Silks, LAP; Williams, RF; Wu, R | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Boreux, R; De Mol, P; Hayette, MP; Kabututu, PZ; Kayiba, NK; Likwela, JL; Mvumbi, DM; Mvumbi, GL; Okitolonda, EW; Situakibanza, HNT; Speybroeck, N; Yobi, DM | 1 |
| Bah, S; Dabitao, D; Dama, S; Diakité, M; Diakité, SAS; Doumbia, S; Doumbouya, M; Guindo, MA; Keita, B; Konaté, DS; Sangaré, M; Sanogo, I; Traoré, K | 1 |
| An, HJ; Jeong, HY; Kang, JM; Kim, DJ; Kim, J; Lee, HS; Lee, SH; Lee, SY; Lee, YH; Park, SH; Sung, M; Yang, DH | 1 |
| Adeniyi, OM; Ajibaye, O; Aremu, OI; Asogwa, N; Babamale, OA; Fakayode, O; Fatoba, IM; Iyiola, OA; Omotesho, OB; Opeyemi, OA; Salawu, KM; Shittu, O | 1 |
| Abuaku, B; Ahorlu, C; Awandare, G; Ghansah, A; Koram, KA; Mensah, BA; Myers-Hansen, JL; Ngwa, AA; Oyebola, MK; Wilson, MD | 1 |
| Duah-Quashie, NO; Quashie, NB | 1 |
| Anywar, DA; Auma, MA; Balikagala, B; Emoto, S; Fukuda, N; Hashimoto, M; Hirai, M; Horii, T; Ikeda, M; Kataoka, M; Katuro, OT; Kimura, E; Mita, T; Mori, T; Obwoya, PS; Odongo-Aginya, EI; Ogwang, M; Opio, W; Palacpac, NMQ; Sakurai-Yatsushiro, M; Sekihara, M; Tachibana, SI; Yamauchi, M; Yatsushiro, S | 1 |
| Das, D; Gorde, S; Sijwali, PS; Sudhakar, R; Thanumalayan, S | 1 |
| Ke, S; Leang, R; Leroy, D; Maher, SP; Mairet-Khedim, M; Nardella, F; Roesch, C; Witkowski, B | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Andrianaranjaka, VHI; Jeannoda, V; Rakoto, DAD; Rakotomanga, TA; Rakotosaona, R; Ralinoro, F; Ramanantsahala, AD; Randrianarivo, RH; Ratsimbasoa, A; Ravaoarisoa, É | 1 |
40 review(s) available for amodiaquine and chloroquine
| Article | Year |
|---|---|
The Medicinal Chemistry of Dengue Virus.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Dengue; Dengue Virus; Humans; Molecular Conformation; Structure-Activity Relationship | 2016 |
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
Topics: Chemistry, Pharmaceutical; Humans; Ligands; Nuclear Receptor Subfamily 4, Group A, Member 2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2022 |
[Current information on treatment and prophylaxis of malaria (author's transl)].
Topics: Adolescent; Adult; Amodiaquine; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Female; Humans; Infant; Insect Repellents; Malaria; Male; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinine; Sulfadiazine; Sulfadoxine; Tetracycline | 1979 |
Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives.
Topics: Adult; Aged; Amodiaquine; Behavior; Chloroquine; Consciousness; Delirium; Depression; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Personality; Psychoses, Substance-Induced; Suicide; Suicide, Attempted | 1977 |
Drug-related transient dyskinesias.
Topics: Amodiaquine; Animals; Brain; Brain Stem; Catecholamines; Chloroquine; Humans; Melanins; Movement Disorders; Protein Binding; Protein Biosynthesis; Pyrogens; Receptors, Dopamine; Time Factors | 1979 |
The chemoprophylaxis of malaria.
Topics: Amodiaquine; Animals; Chloroquine; Dapsone; Drug Combinations; Drug Resistance; Malaria; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 1987 |
Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Half-Life; Humans; Kinetics; Male; Mefloquine; Mice; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine; Sulfalene | 1985 |
Recent advances in antimalarial chemotherapy and drug resistance.
Topics: Agglutination; Amodiaquine; Animals; Anti-Bacterial Agents; Antimalarials; Chloroquine; Cross Reactions; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Haplorhini; Humans; Lincomycin; Malaria; Pigments, Biological; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Primaquine; Pyrimethamine; Quinacrine; Quinine; Quinolines; Structure-Activity Relationship; Sulfonamides; Sulfones | 1974 |
The problem of drug-resistant malaria.
Topics: Amodiaquine; Anopheles; Antimalarials; Asia; Chloroquine; Drug Resistance, Microbial; Humans; Insect Vectors; Malaria; Mutation; Plasmodium falciparum; Primaquine; Proguanil; Quinine; South America; Sulfonamides; Sulfones; Tetracycline; Virulence | 1972 |
Development of new antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Folic Acid Antagonists; Humans; Malaria; Methanol; Phenanthrenes; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Quinolines; Research; Sulfadiazine; Sulfonamides; Sulfones; United States | 1972 |
[Importation of malaria into the Federal Republic of Germany including Berlin (West) in the last ten years (1963-1972)].
Topics: Africa; Age Factors; Aircraft; Amodiaquine; Antimalarials; Asia; Berlin; Chloroquine; Disease Outbreaks; Epidemiologic Methods; Europe; Female; Germany, West; Humans; Malaria; Male; Proguanil; Pyrimethamine; Recurrence; Retrospective Studies; Sex Factors; Travel; World Health Organization | 1974 |
New perspectives on the chemotherapy of malaria, filariasis, and leprosy.
Topics: Amodiaquine; Aniline Compounds; Antimalarials; Chloroquine; Cresols; Dapsone; Drug Resistance; Filariasis; Folic Acid Antagonists; Guanidines; Humans; Leprosy; Malaria; Phenethylamines; Plasmodium falciparum; Pyrrolidines; Quinazolines; Quinolines; Schiff Bases; Sulfones | 1974 |
[Anti-sunburn preparations].
Topics: Acetone; Aminobenzoates; Amodiaquine; Ascorbic Acid; Benzimidazoles; Chemical Phenomena; Chemistry; Chloroquine; Dermatologic Agents; Hydrazines; Hypersensitivity; Melanins; Naphthalenes; Nicotinic Acids; Pharmaceutic Aids; Phenols; Photosensitivity Disorders; Pyridines; Quinolines; Radiation Effects; Salicylates; Skin; Skin Absorption; Skin Physiological Phenomena; Sunburn; Sunscreening Agents; Ultraviolet Rays | 1968 |
The pharmacology of the antimalarials. A rational approach to the therapy of resistant falciparum malaria.
Topics: Amodiaquine; Antimalarials; Chemical Phenomena; Chemistry; Chloroquine; Dapsone; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinacrine; Sulfadimethoxine; Sulfisoxazole | 1969 |
Malaria. Chemoprophylaxis and chemotherapy.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dapsone; Drug Resistance, Microbial; Drug Synergism; Humans; Malaria; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine; Pyrimidines; Quinine; Sulfonamides; Triazines | 1971 |
Resistance of P. falciparum to chloroquine in Africa: true or false?
Topics: Acute Disease; Africa; Amodiaquine; Antimalarials; Chloroquine; Proguanil | 1970 |
Malaria prophylaxis in travellers: the current position.
Topics: Africa; Amodiaquine; Antimalarials; Asia; Chloroquine; Culicidae; Drug Resistance; Female; Humans; Infant; Insect Bites and Stings; Latin America; Malaria; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Primaquine; Proguanil; Risk; Travel | 1984 |
Anti-malarials in dermatology.
Topics: Absorption; Amodiaquine; Antimalarials; Chemical Phenomena; Chemistry; Chloroquine; Female; Humans; Hydroxychloroquine; Quinacrine; Skin Diseases | 1982 |
[Drug resistance in malaria].
Topics: Africa; Amodiaquine; Animals; Asia; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; South America; Sulfanilamides | 1980 |
The present status of malaria chemotherapy: mefloquine, a novel antimalarial.
Topics: Amodiaquine; Animals; Antimalarials; Aotus trivirgatus; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dogs; Drug Therapy, Combination; Erythrocytes; Female; Humans; Lethal Dose 50; Macaca mulatta; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Primaquine; Proguanil; Protein Conformation; Pyrimethamine; Quinolines; Rats; Stereoisomerism; Swine | 1981 |
Systematic review of amodiaquine treatment in uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria, Falciparum; Randomized Controlled Trials as Topic; Treatment Outcome | 1996 |
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Interactions; Drug Therapy, Combination; Malaria, Falciparum; Molecular Conformation; Quinidine; Quinine | 1996 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 1998 |
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Topics: Africa, Eastern; Africa, Western; Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Costs; Humans; Malaria; Mefloquine; Patient Selection; Phenanthrenes; Pyrimethamine; Quinine; Safety; Sulfadoxine; Treatment Outcome | 1999 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2000 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2001 |
Amodiaquine for treating malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2003 |
[EXTRAMALARIAL THERAPUETIC APPLICATIONS OF ANTIMALARIAL DRUGS. 1. CLINICAL UTILIZATIONS].
Topics: Amodiaquine; Antimalarials; Chloroquine; Collagen Diseases; Dermatology; Drug Utilization; Epilepsy; Female; Heart Diseases; Hematology; Humans; Hydroxychloroquine; Hypersensitivity; Multiple Sclerosis; Muscular Diseases; Neurology; Parasitic Diseases; Pharmacology; Primaquine; Proguanil; Pyrimethamine; Quinacrine; Quinine; Toxicology; Uterus | 1963 |
Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium.
Topics: Acetylcysteine; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Glutathione; Hemin; Humans; Malaria; Mice; Plasmodium | 2003 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
[Cytochrome P-450 and the response to antimalarial drugs].
Topics: Administration, Oral; Adult; Amodiaquine; Animals; Antimalarials; Biotransformation; Child; Chloroquine; Cytochrome P-450 Enzyme System; Databases as Topic; Disease Models, Animal; Genotype; Humans; Malaria; Malaria, Falciparum; Mefloquine; Mice; Murinae; Mutation; Nutritional Status; Phenotype; Plasmodium berghei; Polymorphism, Genetic; Proguanil; Rats | 2006 |
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chemical Phenomena; Chemistry, Physical; Chloroquine; Drug Resistance; Humans; Plasmodium falciparum; Structure-Activity Relationship | 2006 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sulfadoxine; Treatment Failure | 2006 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
73 trial(s) available for amodiaquine and chloroquine
| Article | Year |
|---|---|
Amodiaquine resistant falciparum malaria in Thailand.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Amodiaquine; Chloroquine; Chromatography; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Hematocrit; Humans; Leukocyte Count; Malaria; Male; Plasmodium falciparum; Thailand | 1975 |
Malaria in infants whose mothers received chemoprophylaxis: response to amodiaquine therapy.
Topics: Administration, Oral; Amodiaquine; Chloroquine; Drug Resistance; Female; Humans; Immunity, Maternally-Acquired; Incidence; Infant; Longitudinal Studies; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Tanzania; Treatment Outcome | 1992 |
Parasitological, clinical and haematological response of children with Plasmodium falciparum to 4-aminoquinolines and to pyrimethamine-sulfadoxine with quinine in western Kenya.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Erythrocyte Count; Female; Hematocrit; Hemoglobins; Hospitals; Humans; Infant; Kenya; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Reticulocytes; Seroepidemiologic Studies; Sulfadoxine | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Sensitivity of falciparum malaria to chloroquine and amodiaquine in four districts of western Kenya (1985-1987).
Topics: Adolescent; Adult; Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Kenya; Malaria, Falciparum; Microbial Sensitivity Tests; Middle Aged | 1991 |
Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Sulfalene; Tanzania; Time Factors | 1991 |
[Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique].
Topics: Adult; Amodiaquine; Animals; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Hemoglobins; Humans; Leukocyte Count; Malaria; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1990 |
Sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and mefloquine in Ibadan, Nigeria.
Topics: Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; In Vitro Techniques; Infant; Malaria; Male; Mefloquine; Nigeria; Plasmodium falciparum; Quinolines | 1988 |
Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1988 |
[Efficacy of amodiaquine, Fansidar and their combination in the treatment of chloroquine-resistant falciparum malaria].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Random Allocation; Sulfadoxine; Sulfanilamides | 1988 |
Efficacy of chemoprophylaxis in preventing Plasmodium falciparum parasitaemia and placental infection in pregnant women in Malawi.
Topics: Amodiaquine; Animals; Chloroquine; Female; Humans; Malaria; Malawi; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious | 1988 |
[In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II. Study of Manaus, Amazonas 1983-1984].
Topics: Adolescent; Adult; Amodiaquine; Animals; Brazil; Chloroquine; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Random Allocation; Sulfadoxine; Sulfanilamides | 1986 |
Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
Topics: Amodiaquine; Animals; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Rwanda; Sulfadoxine; Sulfanilamides | 1988 |
Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1988 |
Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chloroquine; Chlorpromazine; Drug Combinations; Drug Synergism; Female; Humans; Male; Middle Aged; Pyrimethamine; Random Allocation; Schizophrenia; Sulfadoxine | 1988 |
Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides; Time Factors | 1986 |
Amodiaquine less effective than chloroquine in the treatment of falciparum malaria in the Philippines.
Topics: Adolescent; Adult; Amodiaquine; Biological Availability; Chloroquine; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Malaria; Male; Philippines; Plasmodium falciparum; Random Allocation | 1987 |
Orally administered amodiaquine base suspensions in the treatment of acute malaria infections of young children in Nigeria.
Topics: Administration, Oral; Amodiaquine; Blood; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Nigeria; Suspensions | 1974 |
Prophylactic and sporontocidal treatment of chloroquine resistant Plasmodium falciparum from Malaya.
Topics: Adult; Amodiaquine; Anopheles; Antimalarials; Blood; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Resistance, Microbial; Humans; Malaria; Malaysia; Male; Plasmodium falciparum; Primaquine; Proguanil; Pyrimethamine | 1970 |
Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya.
Topics: Adolescent; Amodiaquine; Blood; Child; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Kenya; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 1984 |
Amodiaquine more effective than chloroquine against Plasmodium falciparum malaria on Kenya coast.
Topics: Amodiaquine; Child; Chloroquine; Humans; Kenya; Malaria; Plasmodium falciparum | 1984 |
Antimalarial drugs for rheumatoid arthritis.
Topics: Amodiaquine; Antimalarials; Arthritis, Rheumatoid; Body Weight; Chloroquine; Clinical Trials as Topic; Gold; Humans; Hydroxychloroquine; Kinetics; Penicillamine; Tablets; Vision Disorders | 1983 |
The present status of malaria chemotherapy: mefloquine, a novel antimalarial.
Topics: Amodiaquine; Animals; Antimalarials; Aotus trivirgatus; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dogs; Drug Therapy, Combination; Erythrocytes; Female; Humans; Lethal Dose 50; Macaca mulatta; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Primaquine; Proguanil; Protein Conformation; Pyrimethamine; Quinolines; Rats; Stereoisomerism; Swine | 1981 |
Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1995 |
[Parasitological and clinical response to amodiaquine versus chloroquine in the treatment of Plasmodium falciparum malaria in children in an endemic area].
Topics: Adolescent; Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male | 1994 |
In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1994 |
A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya.
Topics: Adolescent; Adult; Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Costs; Humans; Kenya; Malaria, Falciparum; Prospective Studies; Treatment Failure | 1994 |
Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
Topics: Adolescent; Amodiaquine; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Kenya; Malaria, Falciparum; Microbial Sensitivity Tests; Pyrimethamine; Rural Health; Sulfadoxine; Sulfalene | 1993 |
Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Equatorial Guinea; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1993 |
Chloroquine versus amodiaquine in the treatment of Plasmodium falciparum malaria in northeast India.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Female; Humans; India; Malaria, Falciparum; Male; Middle Aged | 1995 |
A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Gambia; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 1996 |
A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1996 |
Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Chloroquine; Codon; Drug Resistance; Genes, Protozoan; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Selection, Genetic; Tyrosine | 1997 |
Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Senegal; Sulfadoxine | 2001 |
Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Age Factors; Amodiaquine; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Normal Distribution; Parasitemia; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2001 |
A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Gametogenesis; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
The effects of chloroquine, amodiaquine and chloroquine plus chlorpheniramine on the disposition kinetics of the hepatomegaly associated with acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Adolescent; Amodiaquine; Antimalarials; Area Under Curve; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Therapy, Combination; Hepatomegaly; Humans; Infant; Malaria, Falciparum; Prospective Studies; Treatment Outcome | 2002 |
Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda | 2003 |
A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Administration, Oral; Amodiaquine; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Ketotifen; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2003 |
Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2003 |
Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2004 |
Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Uganda | 2004 |
Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sudan; Sulfadoxine; Treatment Outcome | 2004 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine | 2004 |
Plasmodium falciparum hyperparasitaemia in children. Risk factors, treatment outcomes, and gametocytaemia following treatment.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gametogenesis; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Treatment Outcome | 2004 |
Comparison of the in-vitro activity of amodiaquine and its main metabolite, monodesethyl-amodiaquine, in Plasmodium falciparum.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Species Specificity; Thailand | 2003 |
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Evidence-Based Medicine; Female; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sierra Leone; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Ghana; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Patient Dropouts; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Protozoan Proteins; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2005 |
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Health Policy; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Infections; Malaria; Male; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Uganda | 2005 |
Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
[Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire].
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Geography; Humans; Infant; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome; Uganda | 2006 |
Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Treatment Outcome | 2007 |
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
Topics: Adult; Amodiaquine; Antimalarials; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2006 |
Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Genotype; Guinea-Bissau; Humans; Linkage Disequilibrium; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prevalence; Protozoan Proteins; Time Factors | 2007 |
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Madagascar; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Comoros; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
[Open radomized study comparing chloroquine and amodiaquine for treatment of uncomplicated plasmodium falciparum malaria in children in Aboisso, Cote d' Ivoire].
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Cote d'Ivoire; Female; Humans; Infant; Malaria, Falciparum; Male | 2007 |
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2007 |
[Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Colombia; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
Biological and haematological safety profile of oral amodiaquine and chloroquine in healthy volunteers with or without Plasmodium falciparum infection in northeast Tanzania.
Topics: Adolescent; Adult; Agranulocytosis; Amodiaquine; Analysis of Variance; Animals; Antimalarials; Chemical and Drug Induced Liver Injury; Chloroquine; Humans; Liver; Malaria, Falciparum; Male; Middle Aged; Tanzania; Treatment Outcome; Young Adult | 2008 |
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mali; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome | 2010 |
A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Animals; Anthelmintics; Artemisinins; Artesunate; Chloroquine; Humans; Loa; Loiasis; Middle Aged; Quinine; Young Adult | 2010 |
Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Brazil; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Genotype; Humans; Infant; Kaplan-Meier Estimate; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Recurrence; Treatment Failure; Treatment Outcome; Young Adult | 2017 |
Changing Antimalarial Drug Sensitivities in Uganda.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Chloroquine; Drug Resistance; Ethanolamines; Female; Fluorenes; Gene Expression; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinolines; Uganda; Young Adult | 2017 |
355 other study(ies) available for amodiaquine and chloroquine
| Article | Year |
|---|---|
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Topics: Adrenergic beta-Antagonists; Amines; Ammonium Chloride; Antidepressive Agents, Tricyclic; Atorvastatin; Cell Line, Transformed; Diuretics; Hepatocytes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Lysosomes; Monensin; Nigericin; Propranolol; Pyrroles | 2013 |
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
Topics: Aminoquinolines; Animals; Antimalarials; Benzene Derivatives; Humans; Malaria; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2015 |
Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype.
Topics: Antimalarials; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Indoles; Malaria; Molecular Structure; Niacinamide; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2015 |
ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity.
Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2016 |
Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.
Topics: Antimalarials; Benzamides; Dose-Response Relationship, Drug; Hemeproteins; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2016 |
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
Topics: Animals; Antimalarials; Drug Design; Humans; Mice; Piperazine; Plasmodium falciparum; Quinolones; Solubility; Structure-Activity Relationship | 2018 |
New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.
Topics: Alzheimer Disease; Amodiaquine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Cell Line, Tumor; Cell Survival; Chloroquine; Humans; Protein Binding; Structure-Activity Relationship | 2018 |
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Topics: Animals; Antiviral Agents; Chrysenes; Ebolavirus; Hemorrhagic Fever, Ebola; Lysosomes; Mice; Surface-Active Agents; Virus Internalization; Zebrafish | 2019 |
New hybrid trifluoromethylquinolines as antiplasmodium agents.
Topics: Animals; Antimalarials; Cell Line; Drug Discovery; Erythrocytes; Halogenation; Haplorhini; Humans; Malaria; Methylation; Mice; Plasmodium berghei; Plasmodium falciparum; Quinolines | 2019 |
Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles.
Topics: | 2019 |
Hybridization of Fluoro-amodiaquine (FAQ) with Pyrimidines: Synthesis and Antimalarial Efficacy of FAQ-Pyrimidines.
Topics: | 2019 |
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1.
Topics: Amodiaquine; Animals; Cell Line; Chloroquine; Humans; Ligands; Nuclear Magnetic Resonance, Biomolecular; Nuclear Receptor Subfamily 4, Group A, Member 2; Phenylacetates; Protein Binding; Rats; Small Molecule Libraries; Transcription, Genetic | 2020 |
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms.
Topics: Aminoquinolines; Astrocytes; Gene Expression; HEK293 Cells; Humans; Molecular Structure; Nuclear Receptor Subfamily 4, Group A, Member 2; Structure-Activity Relationship | 2021 |
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship | 2021 |
Prevention and treatment of malaria.
Topics: Amodiaquine; Chloroquine; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Quinine; Trimethoprim | 1977 |
Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum.
Topics: Aminoquinolines; Amodiaquine; Animals; Chloroquine; Drug Resistance, Microbial; Female; Haplorhini; Malaria; Male; Plasmodium falciparum | 1977 |
A pocket of controlled malaria in a holoendemic region of West Africa.
Topics: Amodiaquine; Anopheles; Child; Child, Preschool; Chloroquine; Costs and Cost Analysis; Humans; Liberia; Malaria; Mosquito Control; Plasmodium; Splenomegaly | 1979 |
Comparative efficacy of drugs in bovine anaplasmosis.
Topics: Amodiaquine; Anaplasmosis; Animals; Anti-Infective Agents; Body Temperature; Cattle; Cattle Diseases; Chloroquine; Chlortetracycline; Imidocarb; Oxytetracycline; Tetracycline | 1979 |
Chloroquine-resistant falciparum malaria from Irian Jaya (Indonesian New Guinea).
Topics: Amodiaquine; Chloroquine; Drug Resistance; Humans; Malaria; Male; Piperidines; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Quinolines | 1976 |
[Chemotherapy and chemoprophylaxis of malaria (author's transl)].
Topics: Adult; Amodiaquine; Antimalarials; Asia, Southeastern; Central America; Child; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinine; Sulfadoxine; Sulfalene; Travel | 1976 |
In vitro activity of pyronaridine against African strains of Plasmodium falciparum.
Topics: Africa; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Naphthyridines; Plasmodium falciparum | 1992 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.
Topics: Administration, Oral; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine | 1992 |
Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Drug Costs; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1992 |
Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon.
Topics: Adolescent; Adult; Amodiaquine; Animals; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum | 1991 |
Inefficacy of amodiaquine against chloroquine-resistant malaria.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Plasmodium falciparum | 1991 |
Drug use and design in the nineties.
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Calcium Channel Blockers; Chloroquine; Humans; Malaria; Mefloquine; Naphthoquinones; Phenanthrenes; Primaquine; Quinine; Sesquiterpenes; Sulfadoxine | 1991 |
[Prevention and treatment of malaria in expatriates living in Black Africa. Influence of chemoresistance. Investigations conducted in Brazzaville (Congo)].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance, Microbial; Europe; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Stabilization of drug resistance (chloroquine and amodiaquine) of Plasmodium falciparum in semiimmune populations in the Congo.
Topics: Amodiaquine; Animals; Child; Chloroquine; Drug Resistance; Humans; Malaria; Plasmodium falciparum | 1991 |
Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Infection of Aotus vociferans monkeys with different strains of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Anopheles; Cebidae; Chloroquine; Malaria; Mefloquine; Plasmodium falciparum; Time Factors | 1991 |
Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine.
Topics: Adult; Aged; Amodiaquine; Antibodies, Anti-Idiotypic; Chloroquine; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Malaria; Male; Middle Aged; Neutropenia; Primaquine; Quinine | 1991 |
In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Butylated Hydroxytoluene; Chloroquine; Drug Resistance; Drugs, Chinese Herbal; Mefloquine; Molecular Structure; Phenanthrenes; Plasmodium falciparum; Pyridines; Pyrimethamine; Quinine; Sesquiterpenes; Thailand | 1991 |
Structure activity relationships in the pruritogenicity of chloroquine and amodiaquine metabolites in a dog model.
Topics: Amodiaquine; Animals; Chloroquine; Dealkylation; Dogs; Female; Hindlimb; Ischemia; Male; Pruritus; Structure-Activity Relationship | 1991 |
[Comparative efficacy of chloroquine and amodiaquine (25 and 35 mg/kg) in school children infected with P. falciparum (Brazzaville, March 1990)].
Topics: Amodiaquine; Animals; Child; Chloroquine; Congo; Humans; Malaria; Plasmodium falciparum | 1991 |
An in-vitro profile of the action of four antimalarials on indigenous cases of Plasmodium falciparum malaria in Karnataka.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance, Microbial; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine | 1990 |
Determination of amodiaquine in pharmaceuticals by reaction with periodate and spectrophotometry or by high-performance liquid chromatography.
Topics: Amodiaquine; Chloroquine; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Periodic Acid; Primaquine; Spectrophotometry | 1990 |
[Uncomplicated malaria attack in an area with high chloroquine resistance. 2. Evaluation of first-choice therapeutic scheme].
Topics: Amodiaquine; Animals; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria; Male; Plasmodium falciparum | 1990 |
[Plasmodium falciparum drug resistance in the Congo. Evaluation of surveys carried out from 1985 to 1989].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1990 |
The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.
Topics: Amodiaquine; Bone Marrow; Bone Marrow Cells; Cell Survival; Chloroquine; Colony-Forming Units Assay; Granulocytes; Humans; In Vitro Techniques; Leukocytes, Mononuclear | 1990 |
Prophage induction by 4 antimalaria drugs (daraprim, fansidar, nivaquine and camoquine) and in combination with aflatoxin B1.
Topics: Aflatoxin B1; Aflatoxins; Amodiaquine; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Escherichia coli; In Vitro Techniques; Lysogeny; Mutagenicity Tests; Pyrimethamine; Sulfadoxine | 1989 |
A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinolines; Thailand | 1989 |
Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy.
Topics: Adult; Aged; Amodiaquine; Animals; Chloroquine; Colombia; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Middle Aged; Plasmodium vivax; Primaquine | 1989 |
[Surveillance of Plasmodium falciparum drug sensitivity in Yaounde and its surroundings (Cameroon). In vivo and in vitro study].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Humans; In Vitro Techniques; Infant; Malaria; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Plasmodium falciparum; Quinine; Quinolines; Rural Population | 1989 |
[Malaria in Guiana. I. General status of the endemic].
Topics: Adolescent; Adult; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; French Guiana; History, 17th Century; History, 19th Century; History, 20th Century; Humans; Infant; Malaria; Plasmodium falciparum; Plasmodium vivax; Quinine | 1989 |
Curative and preventive treatment of uncomplicated malaria in public health institutions in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Female; Humans; Malaria; Medicine; Nurses; Physicians; Pregnancy; Public Health; Pyrimethamine; Quinine; Specialization; Sulfadoxine; Surveys and Questionnaires | 1989 |
Progress and problems in the diagnosis and treatment of malaria and development of an effective referral system in Papua New Guinea.
Topics: Amodiaquine; Chloroquine; Humans; Laboratories; Malaria; Papua New Guinea; Referral and Consultation | 1989 |
Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Child; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Humans; Injections, Intravenous; Malaria; Middle Aged; Plasmodium falciparum | 1985 |
Chloroquine and amodiaquine resistant falciparum malaria in Rwanda.
Topics: Amodiaquine; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Rwanda | 1985 |
[In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana].
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; French Guiana; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1988 |
Serial studies on the evolution of drug resistance in malaria in an area of east Africa: findings from 1979 up to 1986.
Topics: Age Factors; Amodiaquine; Animals; Antibodies, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinidine; Quinine; Quinolines; Sulfadoxine; Tanzania | 1988 |
In vivo and in vitro sensitivity of Plasmodium falciparum to chloroquine at Lubwe and Kalene in Zambia: use of amodiaquine as an alternative antimalarial drug.
Topics: Adolescent; Amodiaquine; Animals; Child; Chloroquine; Drug Resistance; Humans; Malaria; Plasmodium falciparum; Zambia | 1988 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.
Topics: Adult; Agranulocytosis; Amodiaquine; Antimalarials; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Chloroquine; Female; Granulocytes; Humans; Macrophages; Sulfadoxine | 1986 |
Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
Topics: Amodiaquine; Antimalarials; Blood Glucose; Chloroquine; Humans; Hypoglycemia; Insulin; Mefloquine; Phenanthrenes; Quinidine; Quinolines; Thailand | 1986 |
Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials.
Topics: Aminoquinolines; Amodiaquine; Animals; Biological Transport, Active; Chloroquine; Half-Life; Humans; Hydroxychloroquine; In Vitro Techniques; Liver; Muscles | 1988 |
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.
Topics: Amodiaquine; Antimalarials; Cell Survival; Cell-Free System; Chemotaxis, Leukocyte; Chloroquine; Humans; Mefloquine; Neutrophils; Oxidation-Reduction; Phagocytosis; Quinolines | 1988 |
Evaluation of an in vitro assay system for drug susceptibility of field isolates of Plasmodium falciparum from southern Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Butylated Hydroxytoluene; Chloroquine; Humans; Mefloquine; Parasitology; Phenanthrenes; Plasmodium falciparum; Pyridines; Pyrimethamine; Quinine; Quinolines; Thailand; Triazines | 1988 |
In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chemical Phenomena; Chemistry; Chloroquine; Drug Resistance; Humans; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Thailand | 1988 |
In vitro susceptibility of Plasmodium falciparum to amodiaquine, mefloquine, quinine and chloroquine in Liberia, West Africa.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; Liberia; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
[Pharmacoresistance of Plasmodium falciparum in Rwanda: an in vivo study].
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance, Microbial; Humans; Plasmodium falciparum; Pyrimethamine; Rwanda; Sulfadoxine | 1987 |
In vitro drug response of Plasmodium falciparum in the Philippines: increased resistance to amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Philippines; Plasmodium falciparum; Quinine; Quinolines | 1987 |
Comparison of the relative in vitro activity of chloroquine and amodiaquine against chloroquine-sensitive strains of P. falciparum.
Topics: Amodiaquine; Animals; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Humans; Infant; Plasmodium falciparum | 1987 |
[Drug sensitivity of malaria in a population of children in Pointe-Noire, Congo, in the first half of 1986].
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Resistance; Humans; Infant; Malaria; Plasmodium falciparum | 1987 |
[Drug resistance of Plasmodium falciparum in the Congo. 2. Comparative study in vivo of chloroquine and amodiaquine in Brazzaville schoolchildren (November 1986)].
Topics: Amodiaquine; Animals; Child; Chloroquine; Congo; Drug Resistance; Female; Humans; Malaria; Male; Plasmodium falciparum | 1987 |
[Status of drug resistance of Plasmodium falciparum in the Central African Republic. Results of studies carried out between 1984 and 1986].
Topics: Amodiaquine; Animals; Antimalarials; Central African Republic; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria; Plasmodium falciparum | 1987 |
[2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
[Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].
Topics: Amodiaquine; Angola; Animals; Antimalarials; Burkina Faso; Cameroon; Chloroquine; Drug Resistance; Humans; Madagascar; Malaria; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1987 |
[Development of drug resistance in cases of P. falciparum malaria of African origin in a Parisian hospital. Comparison with field data and therapeutic consequences].
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; France; Humans; Malaria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1987 |
[Current aspects of imported drug-resistant Plasmodium falciparum].
Topics: Adult; Africa, Central; Aged; Aged, 80 and over; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; France; Humans; Malaria; Middle Aged; Military Personnel; Plasmodium falciparum; Quinine | 1987 |
Amodiaquine fails to cure chloroquine resistant Plasmodium falciparum in the Punjab.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Pakistan; Plasmodium falciparum; Quinolines | 1987 |
[Susceptibility of Plasmodium falciparum to chloroquine, piperaquine, amodiaquine, mefloquine and quinine with in vitro microtechnique in Hainan Island].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Synergism; Mefloquine; Plasmodium falciparum; Quinolines | 1987 |
Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.
Topics: Amodiaquine; Animals; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1987 |
[In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of a study conducted on the east coast (July 1985-July 1986)].
Topics: Adolescent; Adult; Aminoquinolines; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Madagascar; Malaria; Plasmodium falciparum | 1987 |
[In vivo and in vitro study of the chemosensitivity of Plasmodium falciparum in Madagascar--1982-1986].
Topics: Adolescent; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Madagascar; Malaria; Plasmodium falciparum | 1987 |
Clinical pharmacology looks at tropical medicine.
Topics: Amodiaquine; Anthelmintics; Antimalarials; Chloroquine; Diethylcarbamazine; Filariasis; Filaricides; Humans; Ivermectin; Malaria; Primaquine | 1987 |
[A fatal case of chloroquine-resistant neuromalaria in a traveller to Cameroon].
Topics: Africa; Amodiaquine; Cameroon; Cerebral Hemorrhage; Chloroquine; Coma; Drug Resistance; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Travel | 1986 |
Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Interactions; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1986 |
[Drug sensitivity of malaria in Madagascar. Comparison in vivo and in vitro of the effects of chloroquine and amodiaquine on P. falciparum in 1984].
Topics: Adolescent; Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Madagascar; Malaria; Plasmodium falciparum | 1986 |
Leucopenia and abnormal liver function in travellers on malaria chemoprophylaxis.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Erythrocyte Count; Female; Humans; Leukocyte Count; Leukopenia; Liver Function Tests; Malaria; Male; Middle Aged; Pyrimethamine; Switzerland; Travel | 1987 |
Lack of effect of antimalarial prophylaxis with chloroquine or amodiaquine in cutaneous leishmaniasis in French Guiana.
Topics: Amodiaquine; Chloroquine; Humans; Leishmaniasis; Malaria | 1986 |
The disposition of amodiaquine in man after oral administration.
Topics: Administration, Oral; Adult; Amodiaquine; Chloroquine; Erythrocytes; Humans; Kinetics; Male; Mass Spectrometry | 1987 |
The role of voluntary village aides in the control of malaria by presumptive treatment of fever. 1. Selection, training and practice.
Topics: Adult; Amodiaquine; Attitude to Health; Chloroquine; Community Health Workers; Female; Fever; Humans; Malaria; Male; Papua New Guinea; Rural Population; Volunteers | 1985 |
The role of voluntary village aides in the control of malaria by presumptive treatment of fever. 2. Impact on village health.
Topics: Adolescent; Amodiaquine; Child; Child, Preschool; Chloroquine; Community Health Workers; Fever; Humans; Infant; Malaria; Papua New Guinea; Patient Compliance; Population Surveillance; Rural Population; Splenomegaly; Time Factors; Volunteers | 1985 |
Studies of resistance to chloroquine, quinine, amodiaquine and mefloquine among Philippine strains of Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Philippines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
Topics: Amodiaquine; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance, Microbial; Geography; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
Malaria prophylaxis for Canadian travellers.
Topics: Amodiaquine; Canada; Chloroquine; Dapsone; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Malaria; Plasmodium; Plasmodium falciparum; Pregnancy; Premedication; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1985 |
[Studies on the chemoresistance of Plasmodium falciparum in Africa: current data].
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinolines | 1985 |
Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; Infant; Madagascar; Malaria; Mefloquine; Microbial Sensitivity Tests; Middle Aged; Phenanthrenes; Piperazines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
[In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of 2 years' study].
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; In Vitro Techniques; Madagascar; Malaria; Phenanthrenes; Piperazines; Plasmodium falciparum; Quinine; Quinolines | 1985 |
Drug-resistant malaria--changing patterns mean difficult decisions.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance, Microbial; Humans; Infant; Kenya; Malaria; Microbial Sensitivity Tests; Plasmodium; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 1985 |
Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography.
Topics: Amodiaquine; Chloroquine; Chromatography, Liquid; Erythrocytes; Humans; Plasma; Spectrophotometry, Ultraviolet | 1986 |
Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama.
Topics: Adult; Amodiaquine; Animals; Anopheles; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Haplorhini; Humans; Malaria; Male; Panama; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Recurrence; Sulfadiazine | 1974 |
Chloroquine-resistant Plasmodium falciparum: difference in the handling of 14C-amodiaquin and 14C-chloroquine.
Topics: Amodiaquine; Animals; Carbon Radioisotopes; Chloroquine; Drug Resistance, Microbial; Erythrocytes; Haplorhini; Plasmodium falciparum | 1973 |
Chloroquine-resistant Plasmodium falciparum: effect of substrate on chloroquine and amodiaquin accumulation.
Topics: Amodiaquine; Animals; Carbon Radioisotopes; Chloroquine; Drug Resistance, Microbial; Erythrocytes; Haplorhini; Plasmodium falciparum | 1974 |
Characterization of a drug resistant strain of Plasmodium falciparum from Burma.
Topics: Adult; Amodiaquine; Anopheles; Chloroquine; Drug Resistance, Microbial; Human Experimentation; Humans; Insect Vectors; Malaria; Male; Myanmar; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine | 1973 |
Mechanism of the pressor effect of amodiaquin and chloroquine in methylamphetamine-pretreated anesthetized dogs.
Topics: Amodiaquine; Amphetamine; Animals; Atropine; Blood Pressure; Carotid Arteries; Catecholamines; Chloroquine; Choline; Dogs; Ethanolamines; Femoral Artery; Hexamethonium Compounds; Muscle, Smooth; Norepinephrine; Quinolines; Reserpine; Sympatholytics; Tolazoline; Xylenes | 1968 |
Mass drug administration as a supplementary attack measure in malaria eradication programme.
Topics: Adolescent; Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Combinations; Humans; Indian Ocean Islands; Infant; Infant, Newborn; Malaria; Primaquine | 1974 |
[UV-spectrophotometry in drug control. 14. Characterization and determination of drugs with quinoline and isoquinoline chromophores].
Topics: Amodiaquine; Chloroquine; Hydroxychloroquine; Isoquinolines; Papaverine; Primaquine; Quinidine; Quinine; Quinolines; Spectrophotometry, Ultraviolet | 1974 |
Plasmodium falciparum malaria in Panama resistant to 4-aminoquinoline drugs.
Topics: Amodiaquine; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Panama; Plasmodium falciparum; Quinine; Quinolines; Time Factors | 1972 |
Preliminary studies on a Philippine strain of Plasmodium falciparum resistant to amodiaquine.
Topics: Adult; Amodiaquine; Body Weight; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Male; Philippines; Plasmodium falciparum; Quinine | 1972 |
Response of drug-resistant Plasmodium falciparum to combined therapy in Panama.
Topics: Adult; Amodiaquine; Child; Chloroquine; Drug Resistance, Microbial; Humans; Infant; Malaria; Panama; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadimethoxine; Sulfonamides | 1972 |
A model in vitro system to test the susceptibility of human malarial parasites to antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dapsone; Drug Resistance, Microbial; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Trimethoprim | 1972 |
Characterisation of a drug resistant strain of Plasmodium falciparum from Sabah.
Topics: Adult; Amodiaquine; Borneo; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Quinine | 1973 |
Malaria in New York City. IV. 1960-1971.
Topics: Adolescent; Adult; Africa, Western; Age Factors; Amodiaquine; Child; Child, Preschool; Chloroquine; Dapsone; Female; Humans; Infant; Infant, Newborn; Malaria; Male; Middle Aged; New York City; Occupations; Plasmodium falciparum; Plasmodium vivax; Primaquine; Pyrimethamine; Seasons; Sex Factors; Vietnam | 1974 |
The chemotherapy and prophylaxis of malaria.
Topics: Adolescent; Adult; Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Malaria; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Pregnancy; Primaquine; Proguanil; Quinine | 1973 |
[Treatment of drug-resistant malaria: animal experiments].
Topics: Amodiaquine; Animals; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Leucomycins; Malaria; Mice; Plasmodium berghei; Pyrimethamine; Quinine; Quinolines; Time Factors | 1974 |
Determination of the drug sensitivity of Plasmodium falciparum.
Topics: Acute Disease; Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Folic Acid Antagonists; Humans; Malaria; Methods; Microbial Sensitivity Tests; Plasmodium falciparum; Time Factors | 1971 |
The routine treatment of malaria.
Topics: Acute Disease; Adolescent; Adult; Amodiaquine; Child; Child, Preschool; Chloroquine; Chronic Disease; Drug Resistance, Microbial; Female; Humans; Infant; Malaria; Male; Plasmodium falciparum; Quinacrine; Quinine; Sulfonamides | 1971 |
The role of drugs in a malaria program.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Humans; Malaria; Primaquine; Proguanil; Pyrimethamine; Quinacrine; Recurrence; Sulfonamides; Sulfones; Trimethoprim | 1972 |
Studies concerning the mechanism of action of antimalarial drugs. II. Inhibition of the incorporation of adenosine-5'-monophosphate- 3 H into nucleic acids of erythrocyte-free malarial parasites.
Topics: Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Amodiaquine; Animals; Antimalarials; Chloroquine; DNA; Erythrocytes; Methods; Naphthalenes; Phenanthridines; Plasmodium; Proguanil; Quinacrine; Quinine; Rats; RNA; Saponins; Triazines; Trimethoprim; Tritium | 1971 |
Is malaria chemosuppression necessary in an infant?
Topics: Age Factors; Amodiaquine; Chloroquine; Disease Reservoirs; Humans; Infant, Newborn; Infant, Newborn, Diseases; Malaria; Mosquito Control | 1970 |
Nonspecific phagocytic activity in rats infected with Plasmodium berghei and treated with amodiaquine or chloroquine.
Topics: Amodiaquine; Animals; Body Weight; Carbon; Chloroquine; Colloids; Injections, Intravenous; Liver; Lung; Malaria; Male; Phagocytosis; Plasmodium; Rats; Species Specificity; Spleen | 1970 |
Adrenergic neurone blockade with chloroquine and amodiaquine.
Topics: Amodiaquine; Anesthetics, Local; Animals; Aorta; Chloroquine; Female; Guinea Pigs; Male; Muscle, Smooth; Norepinephrine; Rabbits; Sensory Receptor Cells; Sympathetic Nervous System; Sympatholytics; Trachea | 1970 |
A medicated salt project in the Kazeroun area, Iran--1962-1967.
Topics: Amodiaquine; Anopheles; Blood; Child; Child, Preschool; Chloroquine; Humans; Infant; Infant, Newborn; Insect Vectors; Iran; Malaria; Plasmodium; Rural Population; Sodium Chloride; Transients and Migrants | 1971 |
[Management of acute malaria].
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Injections, Intramuscular; Malaria; Primaquine; Tropical Medicine | 1968 |
Characteristics and cross-resistance patterns of chloroquine-resistant Plasmodium berghei infections in mice.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Dapsone; Drug Resistance, Microbial; Female; Hematocrit; Isoenzymes; L-Lactate Dehydrogenase; Malaria; Mice; Organ Size; Plasmodium; Primaquine; Pyrimethamine; Quinacrine; Quinine; Rodent Diseases; Serum Albumin; Serum Globulins; Spleen; Splenomegaly; Sulfadiazine | 1968 |
Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance.
Topics: Amodiaquine; Animals; Chloroquine; Dapsone; Malaria; Mice; Plasmodium; Primaquine; Proguanil; Pyrimethamine; Quinacrine; Sulfadiazine; Triazines | 1965 |
Relations among antimalarial drugs: results of studies with cycloguanil-, sulfone-, or chloroquine-resistant Plasmodium berghei in mice.
Topics: Acridines; Amodiaquine; Animals; Antimalarials; Arsenicals; Chloroquine; Dapsone; Drug Resistance, Microbial; In Vitro Techniques; Injections, Subcutaneous; Mice; Plasmodium; Sulfadiazine | 1967 |
Malaria control and primary health care.
Topics: Amodiaquine; Chloroquine; Drug Resistance, Microbial; Humans; Malaria; Papua New Guinea; Plasmodium falciparum | 1983 |
Amodiaquine and chloroquine efficacy against Plasmodium falciparum in Madagascar.
Topics: Amodiaquine; Chloroquine; Humans; Madagascar; Malaria; Plasmodium falciparum | 1984 |
Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; In Vitro Techniques; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Thailand | 1983 |
Plasmodium falciparum in Kisumu, Kenya: differences in sensitivity to amodiaquine and chloroquine in vitro.
Topics: Amodiaquine; Child; Chloroquine; Drug Resistance, Microbial; Female; Humans; Kenya; Malaria; Male; Microbial Sensitivity Tests; Plasmodium falciparum | 1983 |
Evaluation of amodiaquine treatment of chloroquine-resistant Plasmodium falciparum malaria on Zanzibar, 1982.
Topics: Amodiaquine; Child; Child, Preschool; Chloroquine; Drug Evaluation; Drug Resistance; Humans; Infant; Malaria; Plasmodium falciparum; Tanzania | 1983 |
Treatment of chloroquine-resistant Plasmodium falciparum malaria.
Topics: Amodiaquine; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Plasmodium falciparum; Tetracycline | 1984 |
[In vitro sensitivity tests of Plasmodium falciparum samples of the Amazonian Basin (Brazil)].
Topics: Amodiaquine; Animals; Antimalarials; Brazil; Chloroquine; In Vitro Techniques; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines | 1983 |
The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ibadan, Nigeria.
Topics: Amodiaquine; Child; Child, Preschool; Chloroquine; Female; Humans; Infant; Malaria; Male; Microbial Sensitivity Tests; Nigeria; Plasmodium falciparum | 1984 |
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. I. Study in two regions of the west coast].
Topics: Adolescent; Aged; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Resistance, Microbial; Humans; Madagascar; Malaria; Piperazines; Plasmodium falciparum; Quinolines | 1984 |
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. II. Study in two regions of the east coast].
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Child; Chloroquine; Drug Resistance, Microbial; Humans; Madagascar; Malaria; Piperazines; Plasmodium falciparum; Quinolines | 1984 |
[4-Aminoquinoline-sensitivity of Plasmodium falciparum in Madagascar. III. Studies in three regions of the interior].
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Chloroquine; Drug Resistance, Microbial; Humans; Madagascar; Malaria; Piperazines; Plasmodium falciparum; Quinolines | 1984 |
Management of Plasmodium falciparum malaria.
Topics: Amodiaquine; Anemia; Antimalarials; Brain Diseases; Chloroquine; Drug Resistance; Female; Humans; Hypoglycemia; Malaria; Oliguria; Pregnancy; Pregnancy Complications, Infectious; Pulmonary Edema; Pyrimethamine; Quinine; Sulfadoxine | 1984 |
[Drug prevention of malaria].
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; Infant; Malaria | 1983 |
The chemotherapy of rodent malaria XXXIII. The activity of chloroquine and related blood schizontocides and of some analogues in drug-induced pigment clumping.
Topics: Amodiaquine; Animals; Chloroquine; Cyclic N-Oxides; Dose-Response Relationship, Drug; Erythrocytes; Pigmentation; Plasmodium berghei; Quinacrine | 1982 |
Inhibition of diamine oxidase by antimalarial drugs.
Topics: Amine Oxidase (Copper-Containing); Amodiaquine; Animals; Antimalarials; Chloroquine; In Vitro Techniques; Intestine, Small; Male; Putrescine; Quinacrine; Rats | 1980 |
Drug-induced lipidoses of the cornea and conjunctiva.
Topics: Amiodarone; Amodiaquine; Chloroquine; Conjunctival Diseases; Corneal Diseases; Fabry Disease; Female; Gentamicins; Humans; Hydroquinones; Lipidoses; Male; Tilorone | 1981 |
In vitro response of Plasmodium falciparum in Thailand to antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Cells, Cultured; Chloroquine; Drug Resistance, Microbial; Female; Humans; Male; Plasmodium falciparum; Quinine; Thailand | 1980 |
Chloroquine resistant Plasmodium falciparum malaria in East New Britain, Papua New Guinea.
Topics: Amodiaquine; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria; Plasmodium falciparum | 1980 |
Malaria and growth stunting in young children of the highlands of Papua New Guinea.
Topics: Amodiaquine; Anthropometry; Child; Child, Preschool; Chloroquine; Female; Growth Disorders; Health Surveys; Humans; Infant; Infant, Newborn; Malaria; New Guinea; Nutrition Disorders; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Infectious | 1980 |
Response to 600 mg amodiaquine base with 45 mg primaquine as presumptive treatment in chloroquine resistant Plasmodium falciparum infection in Assam.
Topics: Adolescent; Adult; Amodiaquine; Child; Chloroquine; Drug Resistance, Microbial; Humans; India; Infant; Malaria; Plasmodium falciparum; Primaquine | 1980 |
Acute malaria in children in Madang: endemicity, clinical presentation and treatment.
Topics: Amodiaquine; Child, Preschool; Chloroquine; Drug Resistance; Humans; Malaria; Papua New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1981 |
Use and misuse of 4-aminoquinoline antimalarials in tropical Africa and re-examination of itch reaction to these drugs.
Topics: Amodiaquine; Chloroquine; Health Surveys; Humans; Malaria; Nigeria; Pruritus | 1981 |
In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Equatorial Guinea; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
Comparative efficacy of chloroquine and amodiaquine in Plasmodium falciparum strain of north-eastern India.
Topics: Amodiaquine; Animals; Chloroquine; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Time Factors | 1994 |
[Cytokines and malaria. A study of TNF-alpha, IL1-beta, IL6 and IL2R in 28 patients].
Topics: Adolescent; Adult; Amodiaquine; C-Reactive Protein; Chloroquine; Humans; Interleukin-1; Interleukin-6; Leukocyte Count; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Middle Aged; Neutrophils; Platelet Count; Prognosis; Receptors, Interleukin-2; Retrospective Studies; Tumor Necrosis Factor-alpha | 1994 |
Photoaffinity labeling of chloroquine-binding proteins in Plasmodium falciparum.
Topics: Affinity Labels; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Carrier Proteins; Chloroquine; Indicators and Reagents; Iodine Radioisotopes; Kinetics; Magnetic Resonance Spectroscopy; Molecular Structure; Plasmodium falciparum; Protozoan Proteins; Quinine | 1994 |
Intracellular proteolysis of poliovirus eclipse particles is abortive.
Topics: Amodiaquine; Biological Transport; Chloroquine; Chlorpromazine; HeLa Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Monensin; Poliovirus; Viral Proteins; Virion | 1994 |
Experimental infections of Anopheles gambiae with Plasmodium falciparum of naturally infected gametocyte carriers in Cameroon: factors influencing the infectivity to mosquitoes.
Topics: ABO Blood-Group System; Adolescent; Adult; Age Factors; Amodiaquine; Animals; Anopheles; Aspirin; Body Temperature; Cameroon; Carrier State; Chi-Square Distribution; Child; Child, Preschool; Chloroquine; Female; Humans; Insect Vectors; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Regression Analysis; Sex Factors | 1993 |
The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine.
Topics: Amodiaquine; Animals; Chloroquine; Fluorine; Molecular Structure; Oxidation-Reduction; Plasmodium falciparum; Structure-Activity Relationship | 1994 |
In vitro responses of P. falciparum parasites to chloroquine, amodiaquine and quinine in two ecological zones in Ghana.
Topics: Amodiaquine; Animals; Child; Chloroquine; Drug Resistance; Ghana; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinine; Rural Population; Urban Population | 1993 |
Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
Topics: Adolescent; Adult; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Hemoglobins; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinine; Regression Analysis; Sickle Cell Trait; Tanzania | 1993 |
Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteers.
Topics: Adult; Amodiaquine; Animals; Chloroquine; Diffusion Chambers, Culture; Erythrocytes; Half-Life; Humans; Leukocytes; Male; Plasmodium falciparum; Spectrophotometry, Ultraviolet | 1993 |
Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Iran; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1993 |
In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Plasmodium falciparum; Regression Analysis | 1993 |
[Sensitivity in vivo and in vitro of Plasmodium falciparum to chloroquine and amodiaquine in Bangangte (west Cameroon)].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Middle Aged; Plasmodium falciparum | 1995 |
Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine.
Topics: Adenosine Triphosphate; Ammonium Chloride; Amodiaquine; Animals; Anti-Bacterial Agents; Antimalarials; Biological Transport, Active; Chloroquine; Enzyme Inhibitors; Glucose; Hydrogen-Ion Concentration; Ionophores; Kinetics; Macrolides; Nigericin; Plasmodium falciparum; Proton-Translocating ATPases; Protons | 1996 |
Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component.
Topics: Alkylation; Amodiaquine; Animals; Antimalarials; Calcium Channel Blockers; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chloroquine; Drug Resistance; Glutathione; Humans; In Vitro Techniques; Leukocytes; Plasmodium falciparum; Verapamil | 1996 |
Amodiaquine.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Chloroquine; Drug Resistance; Health Policy; Humans; Malaria | 1996 |
Investigations of B- and beta-hematin.
Topics: Amodiaquine; Chloroquine; Hemin; Hydrogen Bonding; Hydrogen-Ion Concentration; Indicators and Reagents; Kinetics; Models, Structural; Quinidine; Solubility; Spectroscopy, Fourier Transform Infrared | 1997 |
New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Mannich Bases; Microbial Sensitivity Tests; Naphthyridines; Plasmodium falciparum; Quinolines; Saimiri; Structure-Activity Relationship | 1997 |
Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Mefloquine; Naphthyridines; Plasmodium falciparum; Quinacrine; Quinine | 1996 |
In-vivo resistance of Plasmodium falciparum to chloroquine and amodiaquine in south Cameroon and age-related efficacy of the drugs.
Topics: Adolescent; Age Factors; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Prevalence; Treatment Outcome | 1997 |
Effect of antimalarial drugs on rat enterocyte mitochondrial phospholipase D activity.
Topics: Amodiaquine; Animals; Antimalarials; Calcium; Chloroquine; Enzyme Activation; Intestines; Mitochondria; Oxidants; Phosphatidic Acids; Phosphatidylethanolamines; Phospholipase D; Polyamines; Primaquine; Rats | 1998 |
Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinine | 1998 |
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Case-Control Studies; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Male; Papua New Guinea; Parasitemia; Plasmodium falciparum; Prevalence; Quinine; Recurrence; Treatment Failure | 1996 |
In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; China; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; Laos; Microbial Sensitivity Tests; Myanmar; Naphthyridines; Plasmodium falciparum; Quinine; Sesquiterpenes | 1997 |
[Surveillance of the in vivo sensitivity of Plasmodium falciparum to antimalarial agents: the results of initial tests of the OCEAC Malaria Network].
Topics: Africa, Central; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chloroquine; Congo; Drug Resistance; Endemic Diseases; Equatorial Guinea; Female; Gabon; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Population Surveillance; Reproducibility of Results | 1997 |
In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Naphthyridines; Plasmodium falciparum; Quinine | 1998 |
Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols.
Topics: Amodiaquine; Antimalarials; Chloroquine; Hemoglobins; Humans; Leucine; Mefloquine; Phenanthrenes; Primaquine; Protease Inhibitors | 1998 |
Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Glutathione; Heme; Plasmodium falciparum | 1998 |
Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Bone Marrow; Chloroquine; Chromosome Aberrations; Male; Mice; Mutagenicity Tests; Mutagens; Primaquine; Salmonella typhimurium; Sister Chromatid Exchange | 1998 |
In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance, Microbial; Gabon; Humans; Infant; Malaria, Falciparum; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 1998 |
In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Gabon; Humans; Infant; Malaria, Falciparum; Naphthyridines; Phenanthrenes; Plasmodium falciparum; Quinine | 1999 |
Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Glutathione; Hemin; Humans; In Vitro Techniques; Kinetics; Plasmodium falciparum | 1999 |
Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Chromosome Mapping; DNA Primers; DNA, Protozoan; Drug Resistance, Multiple; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Quinine; Scintillation Counting; Sequence Analysis, DNA; Thailand | 1999 |
Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.
Topics: Amodiaquine; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimalarials; Artemether; Artemisinins; Chloroquine; Doxycycline; Drug Resistance; Erythrocytes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Scintillation Counting; Senegal; Sesquiterpenes; Statistics, Nonparametric; Triazines | 2000 |
Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study.
Topics: Amodiaquine; Antimalarials; Binding Sites; Calorimetry; Chloroquine; Hemin; Hydrogen-Ion Concentration; Mefloquine; Octoxynol; Quinidine; Quinine; Solubility; Spectrophotometry, Ultraviolet; Temperature; Thermodynamics; Titrimetry | 2000 |
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
Topics: Adaptation, Physiological; Adult; Amodiaquine; Animals; Antimalarials; Aotidae; Child; Chloroquine; Disease Models, Animal; Drug Resistance; Female; Humans; Indonesia; Malaria, Vivax; Male; Mefloquine; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy | 2000 |
[Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2001 |
[Evaluation of efficacy and tolerance of amodiaquine versus chloroquine in the treatment of uncomplicated malaria outbreak in children of Gabon].
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Time Factors | 2001 |
Amodiaquine: the exempted antimalarial drug in Ethiopia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Ethiopia; Humans; Malaria; Plasmodium falciparum; Prodrugs | 1998 |
Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes | 2002 |
[Management of child fever in the battle against malaria in Brazzaville].
Topics: Amodiaquine; Antimalarials; Asthenia; Child, Preschool; Chills; Chloroquine; Congo; Diarrhea; Fever; Humans; Malaria, Falciparum; Surveys and Questionnaires; Vomiting | 2002 |
Resistance of Plamodium falciparum to antimalarial drugs in Zaragoza (Antioquia, Colombia), 1998.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance; Humans; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2002 |
Molecular epidemiology of malaria in cameroon. IX. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children.
Topics: Amodiaquine; Animals; Antimalarials; Cameroon; Child, Preschool; Chloroquine; Chromatography, High Pressure Liquid; DNA Primers; DNA, Protozoan; Drug Resistance; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Secondary Prevention | 2002 |
[Center of multidrug-resistant malaria in a forest zone of Cameroon revisited after 14 years].
Topics: Amodiaquine; Animals; Cameroon; Chloroquine; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Quinine; Trees | 2002 |
Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Base Sequence; Cameroon; Child; Child, Preschool; Chloroquine; DNA Primers; Drug Combinations; Drug Resistance, Multiple; Genetic Markers; Humans; Malaria, Falciparum; Molecular Epidemiology; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2002 |
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Genes, Protozoan; Haplotypes; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine; Sesquiterpenes; Transfection; Verapamil | 2002 |
Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand.
Topics: Amodiaquine; Animals; Antimalarials; ATP-Binding Cassette Transporters; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Gene Frequency; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Thailand | 2002 |
High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples.
Topics: Amodiaquine; Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Humans | 2003 |
[Comparison of sensitivity of artesunate-sensitive and artesunate-resistant Plasmodium falciparum to chloroquine and amodiaquine].
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Drug Synergism; Plasmodium falciparum; Sesquiterpenes | 1999 |
[Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 1999 |
In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Triazines | 2002 |
Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya.
Topics: Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Commerce; Drug Combinations; Female; Guideline Adherence; Health Education; Humans; Kenya; Malaria; Male; Pyrimethamine; Rural Health Services; Sulfadoxine; Urban Health Services | 2003 |
Screening of antimalarials against P. gallinaceum in chicks.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chickens; Chloroquine; Malaria; Proguanil; Quinacrine; Quinine; Sulfadiazine | 1952 |
[Results of experiences with chloroquine, proguanil and amodiaquine in the prophylaxis of malaria].
Topics: Amodiaquine; Chloroquine; Humans; Malaria; Proguanil | 1952 |
A comparison of the antimalarial effects of suppressive doses of chloroquine, amodiaquin, and pyrimethamine.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria; Pyrimethamine | 1954 |
Nivaquine and camoquin in malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Malaria; Quinolines | 1954 |
Comparative study of chloroquine and amodiaquin in the treatment of giardiasis.
Topics: Amodiaquine; Antimalarials; Chloroquine; Giardiasis | 1954 |
[Medicinal prophylaxis of malaria by monthly doses of chloroquine and amodiaquine].
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria | 1954 |
Therapeutic trials with pyrimethamine (daraprim), resochin, amodiaquin (camoquin) and quinine.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria; Pyrimethamine; Quinine | 1953 |
The treatment of acute malaria with single oral doses of amodiaquin, chloroquine, hydroxychloroquine and pyrimethamine.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Malaria; Pyrimethamine | 1954 |
Potentialities of monthly doses of camoquin and a gametocidal drug in malaria control.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria | 1955 |
Treatment on malaria with single doses of mepacrine, chloroquine and amodiaquin.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria; Quinacrine | 1955 |
Anticholinergic actions of chloroquine and camoquin on smooth and cardiac muscles.
Topics: Acetylcholine; Amodiaquine; Antimalarials; Chloroquine; Cholinergic Antagonists; Humans; Muscles; Myocardium; Synaptic Transmission | 1956 |
[Treatment of lupus erythematosus with crystalline synthetic antimalarials: nivaquine & flavoquine].
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic | 1957 |
Comparative assessment of chloroquine and amodiaquine as malaria suppressives in Nigeria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria; Nigeria | 1958 |
The use of amodiaquin (camoquin) in the treatment of polymorphous light eruption.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dermatitis, Contact; Humans; Skin Diseases; Sunlight | 1958 |
Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; ATP-Binding Cassette Transporters; Chloroquine; Drug Resistance, Multiple; Genetic Variation; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Sudan | 2003 |
Single dose treatment of malaria with amodiaquin chloroquine and mepacrine in a semi-immune poplation.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria; Quinacrine | 1960 |
[Corneal changes following the use of chloroquine and amodiaquine].
Topics: Amodiaquine; Antimalarials; Chloroquine; Cornea; Humans | 1961 |
Amodiaquine and hydroxychloroquine resistance in Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Hydroxychloroquine; Malaria; Plasmodium falciparum | 1961 |
[Evaluation of antimalarials for rheumatoid arthritis].
Topics: Amodiaquine; Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Humans; Hydroxychloroquine | 1962 |
[The treatment of rheumatoid polyarthritis by synthetic antimalarials].
Topics: Amodiaquine; Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Humans; Hydroxychloroquine | 1962 |
In vivo and in vitro effects of antimalarials on Histoplasma capsulatum.
Topics: Amodiaquine; Antimalarials; Chloroquine; Histoplasma; Humans; In Vitro Techniques; Primaquine; Quinacrine | 1962 |
Oral contraceptives. VII. Antimalarials as antifertility agents.
Topics: Amodiaquine; Antimalarials; Chloroquine; Contraceptive Agents; Contraceptives, Oral; Female; Humans; Proguanil; Pyrimethamine; Quinacrine | 1962 |
Failure of chloroquine and amodiaquine to suppress Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Hyperthermia, Induced; Plasmodium; Plasmodium falciparum | 1962 |
[ON DARK PIGMENTATIONS DUE TO ATABRINE AND AMODIAQUINE].
Topics: Amodiaquine; Chloroquine; Pigmentation; Pigmentation Disorders; Quinacrine; Toxicology | 1963 |
DRUG RESISTANCE IN PLASMODIUM FALCIPARUM FROM THAILAND.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Microbial; Humans; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinacrine; Quinine; Thailand | 1963 |
ANTIMALARIAL DRUG TRIALS ON A MULTIRESISTANT STRAIN OF PLASMODIUM FALCIPARUM.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Microbial; Humans; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Thailand | 1963 |
ANTIMALARIAL DRUGS ON THE AUTOMATICITY OF SINO-AURICULAR AND ATRIO-VENTRICULAR NODES.
Topics: Administration, Intravenous; Amodiaquine; Animals; Anti-Arrhythmia Agents; Antimalarials; Atrioventricular Node; Atropine; Chloroquine; Dogs; Heart Conduction System; Humans; Hydroxychloroquine; Hypotension; Injections, Intravenous; Primaquine; Quinacrine; Quinidine; Research; Statistics as Topic | 1963 |
AN EVALUATION OF ANTIMALARIAL COMBINATIONS AGAINST PLASMODIUM BERGHEI IN THE MOUSE.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Erythrocytes; Mice; Plasmodium; Plasmodium berghei; Primaquine; Pyrimethamine; Research | 1963 |
[ON THE CARDIOTOXIC EFFECTS OF SOME ANTIMALARIAL AGENTS IN ANIMAL EXPERIMENTS].
Topics: Amodiaquine; Animal Experimentation; Animals; Antimalarials; Cardiac Complexes, Premature; Cats; Chloroquine; Electrocardiography; Heart Block; Heart Function Tests; Pharmacology; Primaquine; Research; Toxicology | 1963 |
HYPOTENSIVE ACTION OF CHLOROQUINE AND AMODIAQUINE.
Topics: Amodiaquine; Animals; Anura; Blood Pressure; Blood Pressure Determination; Chloroquine; Dogs; Epinephrine; Heart; Pharmacology; Rabbits; Research | 1964 |
THE TREATMENT OF VITILIGO WITH A COMBINATION OF PSORALENS AND QUINOLINES.
Topics: Amodiaquine; Chloroquine; Copper; Coumarins; Dermatitis, Phototoxic; Furocoumarins; Humans; Iron; Photosensitivity Disorders; Quinolines; Sunlight; Toxicology; Ultraviolet Rays; Vitiligo | 1964 |
FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. II. DEVELOPMENT AND PERSISTENCE OF ANTIBODIES TO PLASMODIUM FALCIPARUM.
Topics: Amodiaquine; Antibodies; Antigen-Antibody Reactions; Chloroquine; Fluorescent Antibody Technique; Humans; Immune Sera; Malaria; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Quinine; Vaccination | 1964 |
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND.
Topics: Amodiaquine; Antimalarials; Asia, Southeastern; Biomedical Research; Chloroquine; Drug Resistance; Drug Resistance, Microbial; Humans; Hydroxychloroquine; Malaria; Malaria, Falciparum; Pharmacology; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinacrine; Quinine; Thailand | 1964 |
[A PATIENT WITH TROPICAL MALARIA].
Topics: Amodiaquine; Antimalarials; Chloroquine; Dosage Forms; Drug Resistance; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Primaquine; Quinine | 1964 |
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM.
Topics: Amodiaquine; Antimalarials; Biomedical Research; Chloroquine; Drug Therapy; Humans; Malaria; Malaria, Falciparum; Pharmacology; Plasmodium falciparum; Pyrimethamine; Quinine; Statistics as Topic; Vietnam | 1964 |
MALARIA IN CHILDHOOD MODERN CONCEPTS OF IMMUNITY, TREATMENT, PROPHYLAXIS.
Topics: Amodiaquine; Child; Chloroquine; Diagnosis; Drug Therapy; Epidemiology; Humans; Infant; Infant, Newborn; Malaria; Proguanil; Pyrimethamine | 1965 |
SOME FEATURES OF MALARIA IN DILI, PORTUGUESE TIMOR, DURING 1963-64.
Topics: Amodiaquine; Anemia; Chloroquine; Clinical Laboratory Techniques; Drug Therapy; Epidemiology; Humans; Indonesia; Malaria; Proguanil; Pyrimethamine; Seasons | 1965 |
Field trials of nivaquine, camoquin and resochin against human malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Humans; Malaria; Quinolines; Uricosuric Agents | 1954 |
Amodiaquine and hydroxychloroquine in rheumatoid arthritis.
Topics: Amodiaquine; Antimalarials; Arthritis, Rheumatoid; Chloroquine; Humans; Hydroxychloroquine | 1959 |
Molecular epidemiology of malaria in Cameroon. XV. Experimental studies on serum substitutes and supplements and alternative culture media for in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Culture Media; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Serum Albumin | 2003 |
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
Topics: Africa, Eastern; Amodiaquine; Antimalarials; Chloroquine; Disease Susceptibility; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Malaria; Parasitic Sensitivity Tests; Predictive Value of Tests; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Cell Line; Chloride Channels; Chloroquine; Drug Resistance; Drug Synergism; Hydrophobic and Hydrophilic Interactions; Ion Channels; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Transfection; Verapamil | 2003 |
Amodiaquine treatment of uncomplicated malaria in children, in an area of chloroquine-resistant Plasmodium falciparum in north-central Nigeria.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Treatment Outcome | 2003 |
[Misunderstood neurological side effects of amodiaquine: apropos of 35 cases in children at Central University Hospital of Yopougon at Abidjan, Côte d' Ivoire].
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Resistance; Endemic Diseases; Humans; Infant; Malaria, Falciparum; Nervous System Diseases; Retrospective Studies | 2003 |
Trial of enteric-coated camoquin in intestinal amebiasis.
Topics: Amebiasis; Amodiaquine; Chloroquine; Dysentery, Amebic; Humans | 1950 |
Chemotherapy of amebic hepatitis in hamsters with emetine, chloroquine, amodiaquin (camoquin), quinacrine and other drugs.
Topics: Amebiasis; Amodiaquine; Chloroquine; Dysentery, Amebic; Emetine; Hepatitis; Liver Diseases; Quinacrine | 1951 |
Treatment of malaria with a single dose of amodiaquine or chloroquine.
Topics: Amodiaquine; Chloroquine; Humans; Malaria | 1952 |
Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea.
Topics: Aminoquinolines; Amodiaquine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Treatment Failure | 2004 |
Structure of the amodiaquine-FPIX mu oxo dimer solution complex at atomic resolution.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Resistance; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Quinidine; Quinine | 2004 |
Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Variation; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2004 |
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Central African Republic; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Sulfadoxine | 2005 |
Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Health Care Costs; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Quinine; Rural Health; Senegal; Sesquiterpenes | 2005 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad.
Topics: Amodiaquine; Animals; Chad; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Genes, Protozoan; Genotype; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Population | 2006 |
Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?
Topics: Amodiaquine; Anemia; Animals; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria; Plasmodium falciparum; Sesquiterpenes | 2006 |
In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance, Multiple; Female; Humans; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Rwanda; Sesquiterpenes | 2006 |
The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Protocols; Drug Combinations; Health Care Costs; Health Education; Health Personnel; Health Policy; Humans; Malaria, Falciparum; Practice Guidelines as Topic; Pyrimethamine; Sulfadoxine; Tanzania | 2006 |
Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Plasmodium falciparum; Sesquiterpenes | 2006 |
Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Gene Frequency; Haplotypes; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Tanzania | 2006 |
[Knowledge and practice among health workers from the Thiès region with regard to new malaria treatment policies].
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Competence; Community Health Services; Drug Combinations; Drug Resistance; Education, Nursing; Guideline Adherence; Health Personnel; Health Policy; Health Promotion; Humans; Malaria, Falciparum; Patient Education as Topic; Practice Guidelines as Topic; Pyrimethamine; Rural Health Services; Senegal; Sulfadoxine; Workforce | 2006 |
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.
Topics: Africa; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Female; Genotype; Humans; Infant; Malaria; Male; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Risk; Sulfadoxine; Treatment Outcome | 2006 |
Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Health Policy; Humans; Malaria, Falciparum; Molecular Epidemiology; Pyrimethamine; Sulfadoxine | 2006 |
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory conc
Topics: Africa; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Parasitic Sensitivity Tests; Plasmodium falciparum; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Practical HPLC methods for the quantitative determination of common antimalarials in Africa.
Topics: Africa; Amodiaquine; Antimalarials; Chloroquine; Chromatography, High Pressure Liquid; Humans; Pyrimethamine; Reproducibility of Results; Sulfadoxine | 2007 |
Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Gametogenesis; Histamine H1 Antagonists; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
Chloroquine-resistant malaria in Malawi.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Malawi; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins | 2007 |
A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Glutathione; Heme; Indicators and Reagents; Mefloquine; Methylene Blue; o-Phthalaldehyde; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Spectrometry, Fluorescence | 2007 |
Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Antagonism; Drug Combinations; Drug Interactions; Drug Resistance; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes; Tritium | 2007 |
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Resistance; Ghana; Humans; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives.
Topics: Amines; Aminoquinolines; Amodiaquine; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Female; Humans; Magnetic Resonance Spectroscopy; Quinolines; Spectrometry, Mass, Fast Atom Bombardment; Structure-Activity Relationship | 2008 |
Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Protozoan Proteins; Quinine; Rural Population | 2007 |
Large-scale surveillance of Plasmodium falciparum crt(K76T) in northern Ghana.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Genes, Protozoan; Genotype; Ghana; Humans; Lactones; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Population Surveillance; Sesquiterpenes | 2007 |
Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Synergism; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins | 2007 |
[Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2007 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
A simple technique for the detection of anti-malarial drug formulations and their presence in human urine.
Topics: Amodiaquine; Antimalarials; Biological Assay; Biological Availability; Chloroquine; Chromatography, Thin Layer; Fraud; Humans; Malaria; Primaquine; Product Surveillance, Postmarketing; Pyrimethamine; Quality Control; Quinine; Sulfadoxine | 2006 |
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
Topics: Algorithms; Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Computer Simulation; Drug Resistance; Malaria; Mefloquine; Models, Theoretical; Pyrimethamine; Quinine | 2008 |
Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Treatment Failure; Treatment Outcome | 2008 |
Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Blotting, Western; Chloroquine; Endocytosis; Erythrocytes; Hemoglobins; Humans; Mefloquine; Peroxidase; Phenanthrenes; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Quinolines | 2008 |
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Clinical Protocols; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Colombia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Protozoan Proteins | 2008 |
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.
Topics: Aminoquinolines; Amodiaquine; Animals; Chloroquine; Drug Resistance, Bacterial; Ferrous Compounds; Mefloquine; Membrane Transport Proteins; Metallocenes; Microsatellite Repeats; Molecular Structure; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines | 2008 |
Lysosomotropic drugs inhibit maturation of transforming growth factor-beta.
Topics: Amodiaquine; Animals; Azithromycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Cell Line; Cell Line, Tumor; Chloroquine; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Furin; Humans; Hydroxychloroquine; Kinetics; Lysosomes; Mice; Mice, Inbred C57BL; Phosphorylation; Stem Cells; Transforming Growth Factor beta | 2008 |
Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006.
Topics: Amodiaquine; Animals; Antimalarials; China; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Plasmodium falciparum | 2008 |
Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Somalia; Sulfadoxine; Treatment Outcome | 2009 |
Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Developing Countries; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Ethanolamines; Evidence-Based Medicine; Female; Fluorenes; Health Surveys; Humans; Incidence; Infant; Lumefantrine; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Refugees; Uganda; Young Adult | 2008 |
Pharmacodynamic interaction between 4-aminoquinolines and retinol in Plasmodium falciparum in vitro.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; In Vitro Techniques; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Thailand; Vitamin A; Vitamins | 2008 |
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
Topics: Adolescent; Age Distribution; Amodiaquine; Animals; Antimalarials; Chloroquine; Confidence Intervals; Drug Resistance; Drug Tolerance; Female; Follow-Up Studies; Humans; Inhibitory Concentration 50; Male; Outpatients; Parasitemia; Plasmodium vivax; Prospective Studies; Recurrence; Rural Health; Time Factors; Treatment Failure; Treatment Outcome | 2009 |
Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Cell Survival; Chloroquine; Dogs; Drug Resistance; Female; Haplorhini; Hepatocytes; Humans; In Vitro Techniques; Malaria; Male; Mice; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Structure-Activity Relationship | 2009 |
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Resistance; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Serial Passage | 2009 |
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; ATP-Binding Cassette Transporters; Chloroquine; Drug Resistance; Geography; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Quantitative Trait Loci; Selection, Genetic | 2009 |
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
Topics: Adolescent; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Young Adult | 2010 |
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
Topics: Amodiaquine; Antimalarials; Atorvastatin; Chloroquine; DNA, Protozoan; Drug Synergism; Gene Dosage; Genotype; Heptanoic Acids; Humans; Inhibitory Concentration 50; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrroles | 2010 |
Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Synergism; Erythrocytes; Flow Cytometry; Humans; Phytosterols; Plasmodium falciparum; Quinine; Solanum; Trophozoites | 2011 |
The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-heme complex.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dimerization; Dose-Response Relationship, Drug; Hemeproteins; Hemin; Hydroxyl Radical; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Malaria, Falciparum; Nitrogen; Plasmodium falciparum; Quinine | 2011 |
Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type.
Topics: Amodiaquine; Angola; Antimalarials; Chloroquine; Codon; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Selection, Genetic; South America; Tanzania | 2010 |
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Chloroquine; Ethanolamines; Fluorenes; Inhibitory Concentration 50; Lumefantrine; Mefloquine; Methylene Blue; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2011 |
Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.
Topics: Amodiaquine; Animals; Antimalarials; Cell Line; Chloroquine; Hemeproteins; Mice; Plasmodium falciparum; Quinolines | 2011 |
A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics.
Topics: Amodiaquine; Animals; Area Under Curve; Blood Specimen Collection; Chloroquine; Chlorthalidone; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Injections, Intravenous; Male; Mice; Mice, Inbred BALB C; Sensitivity and Specificity; Tandem Mass Spectrometry; Time Factors; Tissue Distribution | 2012 |
A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Gabon; Haplotypes; Health Policy; Humans; Malaria; Membrane Transport Proteins; Microsatellite Repeats; Molecular Sequence Data; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Selection, Genetic; Sequence Analysis, DNA | 2011 |
Distribution of human CYP2C8*2 allele in three different African populations.
Topics: Adolescent; Amodiaquine; Antimalarials; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Cytochrome P-450 CYP2C8; Female; Gene Frequency; Genotype; Humans; Madagascar; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Senegal; Uganda | 2012 |
In vitro assessment of drug resistance in Plasmodium falciparum in five States of India.
Topics: Amodiaquine; Artemisinins; Artesunate; Biomarkers, Pharmacological; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; India; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins | 2012 |
Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
Topics: Adamantane; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Heterocyclic Compounds, 1-Ring; Microbial Sensitivity Tests; Peroxides; Plasmodium falciparum; Plasmodium vivax; Quinolines; Spiro Compounds | 2012 |
Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro.
Topics: Amodiaquine; Antimalarials; Biological Transport; Chloroquine; Drug Resistance; Genetic Fitness; Genotype; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum | 2013 |
Augmentation of gastric acid secretion by chloroquine and amodiaquine in the rat stomach.
Topics: Amodiaquine; Animals; Chloroquine; Gastric Acid; Gastric Mucosa; Male; Random Allocation; Rats; Rats, Wistar; Stomach; Up-Regulation | 2012 |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Erythrocytes; Flow Cytometry; High-Throughput Screening Assays; Hydroxamic Acids; Inhibitory Concentration 50; Mefloquine; Merozoites; Plasmodium falciparum; Quinine; Quinolines; Schizonts; Time Factors | 2013 |
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Topics: Amodiaquine; Antimalarials; Artemisinins; Automation, Laboratory; Chloroquine; Drug Resistance; Drug Therapy, Combination; High-Throughput Screening Assays; Internet; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2013 |
Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines; Niger; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2013 |
The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Topics: Amodiaquine; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Fluorenes; Haplotypes; Humans; Inhibitory Concentration 50; Kenya; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Retrospective Studies | 2013 |
Suppressive action of mepacrine, aphacrine, chloroquin, camoquin and proguanil against P. knowlesi in S. rhesus monkeys.
Topics: Amodiaquine; Animals; Chloroquine; Humans; Macaca mulatta; Malaria; Proguanil; Quinacrine | 1950 |
Comparison of the action of paludrine (proguanil), chloroquine and camoquin in single doses.
Topics: Amodiaquine; Chloroquine; Humans; Malaria; Proguanil | 1950 |
Camoquin and chloroquine in the treatment of malaria.
Topics: Amodiaquine; Chloroquine; Humans; Malaria | 1950 |
A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Cross-Sectional Studies; Democratic Republic of the Congo; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Haplotypes; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Sequence Analysis, DNA | 2014 |
Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.
Topics: Amodiaquine; Amoxicillin; Antimalarials; Artemether; Artemisinins; Biosimilar Pharmaceuticals; Chloroquine; Drug Resistance; Health Facilities; Humans; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Primaquine; Quality Control; Quinine | 2014 |
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Topics: Amino Acid Substitution; Amodiaquine; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Datasets as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genetic Markers; Genotype; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Risk Factors | 2014 |
In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Colombia; Drug Resistance; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Quinine | 2014 |
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Biological Transport; Child; Chloroquine; Drug Resistance; Erythrocytes; Ethanolamines; Female; Fluorenes; Gene Expression; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinine; Senegal | 2014 |
Pfcrt 76T and pfmdr1 86Y allele frequency in Plasmodium falciparum isolates and use of self-medication in a rural area of Gabon.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Gabon; Gene Frequency; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Rural Population; Self Medication | 2014 |
Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Plasmodium berghei | 2015 |
Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Clinical Trials as Topic; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Quinolines; Uganda | 2015 |
Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials.
Topics: Amodiaquine; Antimalarials; Atovaquone; Chloroquine; Colorimetry; Heme; Plasmodium falciparum; Pyrimethamine; Trophozoites | 2015 |
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
Topics: Amodiaquine; Animals; Behavior, Animal; Chloroquine; Disease Models, Animal; Ligands; Neurogenesis; Nuclear Receptor Subfamily 4, Group A, Member 2; Oxidopamine; Parkinson Disease; Rats | 2015 |
In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Epidemiological Monitoring; Ethanolamines; Fluorenes; Gene Dosage; Gene Expression; Genotype; Humans; Kenya; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins | 2015 |
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Plasmodium vivax; Protozoan Proteins; Quinolines; Transcription, Genetic; Tubulin | 2016 |
Evaluation of herbal antimalarial MAMA decoction-amodiaquine combination in murine malaria model.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Drugs, Chinese Herbal; Herb-Drug Interactions; Malaria; Mice; Parasitic Sensitivity Tests; Plant Extracts; Plasmodium berghei; Time Factors | 2016 |
Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation.
Topics: Amodiaquine; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Chloroquine; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Inflammation Mediators; Mice; Mice, Inbred C57BL; T-Lymphocytes; Th1 Cells; Treatment Outcome | 2016 |
Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.
Topics: Amino Acid Substitution; Amodiaquine; Antimalarials; Chloroquine; Drug Resistance; Genes, Protozoan; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Peptide Synthases; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins; Senegal; Tetrahydrofolate Dehydrogenase | 2016 |
Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance.
Topics: Amodiaquine; Antimalarials; Biological Transport; Chloroquine; Drug Design; Drug Resistance; Heme; Hemin; Hydrophobic and Hydrophilic Interactions; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vacuoles | 2016 |
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Infant; Infant, Newborn; Kenya; Malaria; Malaria, Falciparum; Malawi; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Rwanda; Sulfadoxine; Tanzania; Uganda | 2016 |
Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Equatorial Guinea; Female; Genetic Loci; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Plasmodium falciparum; Senegal | 2017 |
Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genotype; Genotyping Techniques; Humans; Indoles; Inhibitory Concentration 50; Malaria; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Quinolines; Senegal; Young Adult | 2017 |
The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Malaria; Oxygen; Primaquine; Protein Biosynthesis; Quinolines; Reactive Oxygen Species; RNA, Messenger; Saccharomyces cerevisiae | 2017 |
Deconstructing Quinoline-Class Antimalarials to Identify Fundamental Physicochemical Properties of Beta-Hematin Crystal Growth Inhibitors.
Topics: Amodiaquine; Antimalarials; Chloroquine; Crystallization; Hemin; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Quinolines; Spectrophotometry | 2017 |
Sustained
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Gambia; Humans; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines | 2017 |
Heterologous Expression of a Novel Drug Transporter from the Malaria Parasite Alters Resistance to Quinoline Antimalarials.
Topics: Amino Acid Transport Systems; Amodiaquine; Animals; Antimalarials; Biological Transport; Chloroquine; Conserved Sequence; Drug Resistance; Gene Expression; Humans; Mefloquine; Mutation; Plasmodium chabaudi; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinine; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Transgenes | 2018 |
Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy.
Topics: Amodiaquine; AMP-Activated Protein Kinases; Animals; Antimalarials; Cell Line; Chloroquine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activators; Glucose; Humans; Kidney Tubules; Male; Mice, Inbred C57BL; Mitochondria; Phosphorylation | 2018 |
Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter.
Topics: Amodiaquine; Antimalarials; Artemisinins; Calcium; Cells, Cultured; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Gene Expression; Hemoglobins; Host-Parasite Interactions; Humans; Ion Transport; Ionophores; Membrane Transport Proteins; Monensin; Mutation; Nigericin; Plasmodium falciparum; Protozoan Proteins; Pyrrolidinones | 2018 |
Nanomolar binding affinity of quinine-based antimalarial compounds by the cocaine-binding aptamer.
Topics: Amodiaquine; Antimalarials; Aptamers, Nucleotide; Binding Sites; Chloroquine; Cocaine; Ligands; Mefloquine; Primaquine; Quinine; Thermodynamics | 2018 |
Monocyte phagocytosis of malaria β-haematin in the presence of artemisinin, amodiaquine, chloroquine, doxycycline, primaquine, pyrimethamine and quinine.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Cell Count; Cell Line; Chloroquine; Doxycycline; Electron Probe Microanalysis; Heme; Hemeproteins; Humans; Leukocytes, Mononuclear; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Monocytes; Peroxidase; Phagocytosis; Primaquine; Pyrimethamine; Quinine; Spectrophotometry; Temperature; U937 Cells | 2019 |
Synthesis of stable isotope-labeled chloroquine and amodiaquine and their metabolites.
Topics: Amodiaquine; Chemistry Techniques, Synthetic; Chloroquine; Isotope Labeling; Radiochemistry | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Democratic Republic of the Congo; Dried Blood Spot Testing; Drug Resistance; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Mass Screening; Membrane Transport Proteins; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Prospective Studies; Protozoan Proteins; Young Adult | 2020 |
Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2020 |
Beneficial Effect of Chloroquine and Amodiaquine on Type 1 Diabetic Tubulopathy by Attenuating Mitochondrial Nox4 and Endoplasmic Reticulum Stress.
Topics: Amodiaquine; Animals; Apoptosis; Cells, Cultured; Chloroquine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endoplasmic Reticulum Stress; Glucose; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mitochondria; NADPH Oxidase 4; Reactive Oxygen Species | 2020 |
Clinical Probe of Cyp2C8*2 Mutants in a Malaria Hyperendemic Zone: Evidence from North-Central, Nigeria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Cytochrome P-450 CYP2C8; Drug Resistance; Female; Humans; Malaria; Male; Nigeria; Pharmacogenomic Testing; Plasmodium falciparum | 2020 |
Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Topics: Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Carrier State; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2020 |
Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries.
Topics: Amodiaquine; Chloroquine; COVID-19 Drug Treatment; Drug Resistance; Humans; Malaria; Plasmodium | 2021 |
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Lumefantrine; Mefloquine; Plasmodium falciparum; Quinine; Uganda | 2021 |
Plasmodium falciparum Atg18 localizes to the food vacuole via interaction with the multi-drug resistance protein 1 and phosphatidylinositol 3-phosphate.
Topics: Amodiaquine; Animals; Antimalarials; Autophagy; Autophagy-Related Proteins; Biological Transport; Chloroquine; Erythrocytes; Gene Expression Regulation; Humans; Malaria; Membrane Proteins; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Phosphatidylinositol Phosphates; Plasmodium berghei; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Saccharomyces cerevisiae Proteins; Vacuoles | 2021 |
Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates.
Topics: Amodiaquine; Antimalarials; Asian People; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum | 2021 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
[Pcr-rflp genotyping of
Topics: Amodiaquine; Artesunate; Child; Chloroquine; Drug Resistance; Genotype; Humans; Madagascar; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins | 2022 |